Prof. M.J. van de Vijver MD PhD publications

2021

• Bosma Sophie C. J., Hoogstraat Marlous, van Werkhoven Erik, de Maaker Michiel, van der Leij Femke, Elkhuizen Paula H. M., Fourquet Alain, Poortmans Philip, Boersma Liesbeth J., Bartelink Harry, van de Vijver Marc J. A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients Radiotherapy and oncology 2021;156:127-135 [PubMed]

2020

• Hudeček Jan, Voorwerk Leonie, van Seijen Maartje, Nederlof Iris, de Maaker Michiel, van den Berg Jose, van de Vijver Koen K., Sikorska Karolina, Adams Sylvia, Demaria Sandra, Viale Giuseppe, Nielsen Torsten O., Badve Sunil S., Michiels Stefan, Symmans William Fraser, Sotiriou Christos, Rimm David L., Hewitt Stephen M., Denkert Carsten, Loibl Sibylle, Loi Sherene, Bartlett John M. S., Pruneri Giancarlo, Dillon Deborah A., Cheang Maggie C. U., Tutt Andrew, Hall Jacqueline A., Kos Zuzana, Salgado Roberto, Kok Marleen, Horlings Hugo M., Hyytiäinen Aini, Hida Akira I., Thompson Alastair, Lefevre Alex, Lazar Alexander J., Gown Allen, Lo Amy, Sapino Anna, Madabhushi Anant, Moreira Andre, Richardson Andrea, Vingiani Andrea, Beck Andrew H., Bellizzi Andrew M., Guerrero Angel, Grigoriadis Anita, Ehinger Anna, van de Vijver Marc, van de Vijver Marc Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials npj Breast Cancer 2020;6 (1) [PubMed]
• Bailey Matthew H., Meyerson William U., Dursi Lewis Jonathan, Wang Liang-Bo, Dong Guanlan, Liang Wen-Wei, Weerasinghe Amila, Li Shantao, Li Yize, Kelso Sean, Akbani Rehan, Anur Pavana, Bailey Matthew H., Buchanan Alex, Chiotti Kami, Covington Kyle, Creason Allison, Ding Li, Ellrott Kyle, Fan Yu, Foltz Steven, Getz Gad, Hale Walker, Haussler David, Hess Julian M., Hutter Carolyn M., Kandoth Cyriac, Kasaian Katayoon, Kasapi Melpomeni, Larson Dave, Leshchiner Ignaty, Letaw John, Ma Singer, McLellan Michael D., Men Yifei, Mills Gordon B., Niu Beifang, Peto Myron, Radenbaugh Amie, Reynolds Sheila M., Saksena Gordon, Sofia Heidi, Stewart Chip, Struck Adam J., Stuart Joshua M., Wang Wenyi, Hooijer Gerrit K., Kool Marcel, Liu Jia, van de Vijver Marc J. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y) Nature communications 2020;11 (1) [PubMed]
• Strijker Marin, Soer Eline C., de Pastena Matteo, Creemers Aafke, Balduzzi Alberto, Beagan Jamie J., Busch Olivier R., van Delden Otto M., Halfwerk Hans, van Hooft Jeanin E., van Lienden Krijn P., Marchegiani Giovanni, Meijer Sybren L., van Noesel Carel J., Reinten Roy J., Roos Eva, Schokker Sandor, Verheij Joanne, van de Vijver Marc J., Waasdorp Cynthia, Wilmink Johanna W., Ylstra Bauke, Besselink Marc G., Bijlsma Maarten F., Dijk Frederike, van Laarhoven Hanneke W. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma International journal of cancer. Journal international du cancer 2020;146 (5):1445-1456 [PubMed]
• Bosma Sophie C. J., Leij Femke, Vreeswijk Sandra, Maaker Michiel de, Wesseling Jelle, van de Vijver Marc, Scholten Astrid, Rivera Sofia, Bourgier Celine, Auzac Guillaume, Foukakis Theodoros, Lekberg Tobias, Bongard Desiree, Loo Claudette, Rutgers Emiel, Bartelink Harry, Elkhuizen Paula H. M. Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial International journal of radiation oncology, biology, physics 2020;106 (5):958-967 [PubMed]
• Steins Anne, van Mackelenbergh Madelaine G., van der Zalm Amber P., Klaassen Remy, Serrels Bryan, Goris Sandrine G., Kocher Hemant M., Waasdorp Cynthia, de Jong Joan H., Tekin Cansu, Besselink Marc G., Busch Olivier R., van de Vijver Marc J., Verheij Joanne, Dijk Frederike, van Tienhoven Geertjan, Wilmink Johanna W., Medema Jan Paul, van Laarhoven Hanneke W. M., Bijlsma Maarten F. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1 EMBO reports 2020;21 (5) [PubMed]
• Campbell Peter J., Getz Gad, Korbel Jan O., Stuart Joshua M., Jennings Jennifer L., Stein Lincoln D., Perry Marc D., Nahal-Bose Hardeep K., Ouellette B. F. Francis, Li Constance H., Rheinbay Esther, Nielsen G. Petur, Sgroi Dennis C., Wu Chin-Lee, Faquin William C., Deshpande Vikram, Boutros Paul C., Lazar Alexander J., Hoadley Katherine A., Louis David N., Dursi L. Jonathan, Yung Christina K., Bailey Matthew H., Saksena Gordon, Raine Keiran M., Buchhalter Ivo, Kleinheinz Kortine, Schlesner Matthias, Zhang Junjun, Wang Wenyi, Wheeler David A., Ding Li, Simpson Jared T., O’Connor Brian D., Yakneen Sergei, Ellrott Kyle, Miyoshi Naoki, Butler Adam P., Royo Romina, Shorser Solomon I., Vazquez Miguel, Rausch Tobias, Liu Jia, Hooijer Gerrit K., van de Vijver Marc J., Kool Marcel, Liu Jia, Hooijer Gerrit K., van de Vijver Marc J., Kool Marcel Pan-cancer analysis of whole genomes Nature 2020;578 (7793):82-93 [PubMed]
• Klaassen Remy, Steins Anne, Gurney-Champion Oliver J., Bijlsma Maarten F., van Tienhoven Geertjan, Engelbrecht Marc R. W., van Eijck Casper H. J., Suker Mustafa, Wilmink Johanna W., Besselink Marc G., Busch Olivier R., de Boer Onno J., van de Vijver Marc J., Hooijer Gerrit K. J., Verheij Joanne, Stoker Jaap, Nederveen Aart J., van Laarhoven Hanneke W. M. Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience Molecular oncology 2020;14 (9):2176-2189 [PubMed]
• Kos Zuzana, Roblin Elvire, Kim Rim S., Michiels Stefan, Gallas Brandon D., Chen Weijie, van de Vijver Koen K., Goel Shom, Adams Sylvia, Demaria Sandra, Viale Giuseppe, Nielsen Torsten O., Badve Sunil S., Symmans W. Fraser, Sotiriou Christos, Rimm David L., Hewitt Stephen, Denkert Carsten, Loibl Sibylle, Luen Stephen J., Bartlett John M. S., Savas Peter, Pruneri Giancarlo, Dillon Deborah A., Cheang Maggie Chon U., Tutt Andrew, Hall Jacqueline A., Kok Marleen, Horlings Hugo M., Madabhushi Anant, van der Laak Jeroen, Ciompi Francesco, Laenkholm Anne-Vibeke, Bellolio Enrique, Gruosso Tina, Fox Stephen B., Araya Juan Carlos, Floris Giuseppe, Hudeček Jan, Voorwerk Leonie, Beck Andrew H., Kerner Jen, Larsimont Denis, Declercq Sabine, van den Eynden Gert, Pusztai Lajos, Ehinger Anna, Nederlof Iris, van de Vijver Mark, Nederlof Iris Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer npj Breast Cancer 2020;6 (1) [PubMed]
• Bailey Matthew H., Meyerson William U., Dursi Lewis Jonathan, Wang Liang-Bo, Dong Guanlan, Liang Wen-Wei, Weerasinghe Amila, Li Shantao, Kelso Sean, Akbani Rehan, Anur Pavana, Bailey Matthew H., Buchanan Alex, Chiotti Kami, Covington Kyle, Creason Allison, Ding Li, Ellrott Kyle, Fan Yu, Foltz Steven, Getz Gad, Hale Walker, Haussler David, Hess Julian M., Hutter Carolyn M., Kandoth Cyriac, Kasaian Katayoon, Kasapi Melpomeni, Larson Dave, Leshchiner Ignaty, Letaw John, Ma Singer, McLellan Michael D., Men Yifei, Mills Gordon B., Niu Beifang, Peto Myron, Radenbaugh Amie, Reynolds Sheila M., Saksena Gordon, Sofia Heidi, Stewart Chip, Struck Adam J., Stuart Joshua M., Wang Wenyi, Weinstein John N., Hooijer Gerrit K., Kool Marcel, Liu Jia, van de Vijver Marc J. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples Nature communications 2020;11 (1) [PubMed]
• Li Constance H., Prokopec Stephenie D., Sun Ren X., Yousif Fouad, Schmitz Nathaniel, Al-Shahrour Fatima, Atwal Gurnit, Bailey Peter J., Biankin Andrew V., Boutros Paul C., Campbell Peter J., Chang David K., Cooke Susanna L., Deshpande Vikram, Faltas Bishoy M., Faquin William C., Garraway Levi, Getz Gad, Grimmond Sean M., Haider Syed, Hoadley Katherine A., Jiao Wei, Kaiser Vera B., Karlić Rosa, Kato Mamoru, Kübler Kirsten, Lazar Alexander J., Li Constance H., Louis David N., Margolin Adam, Martin Sancha, Nahal-Bose Hardeep K., Nielsen G. Petur, Nik-Zainal Serena, Omberg Larsson, P’ng Christine, Perry Marc D., Polak Paz, Rheinbay Esther, Rubin Mark A., Semple Colin A., Sgroi Dennis C., Shibata Tatsuhiro, Siebert Reiner, Smith Jaclyn, Stein Lincoln D., Hooijer Gerrit K., Kool Marcel, Liu Jia, van de Vijver Marc J. Sex differences in oncogenic mutational processes Nature communications 2020;11 (1) [PubMed]
• Dijk Frederike, Veenstra Veronique L., Soer Eline C., Dings Mark P. G., Zhao Lan, Halfwerk Johannes B., Hooijer Gerrit K., Damhofer Helene, Marzano Marco, Steins Anne, Waasdorp Cynthia, Busch Olivier R., Besselink Marc G., Tol Johanna A., Welling Lieke, van Rijssen Lennart B., Klompmaker Sjors, Wilmink Hanneke W., van Laarhoven Hanneke W., Medema Jan Paul, Vermeulen Louis, van Hooff Sander R., Koster Jan, Verheij Joanne, van de Vijver Marc J., Wang Xin, Bijlsma Maarten F. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems Scientific reports 2020;10 (1):337 [PubMed]

2019

• Savci-Heijink C. D., Halfwerk H., Koster J., Horlings H. M., van de Vijver M. J. A specific gene expression signature for visceral organ metastasis in breast cancer BMC cancer 2019;19 (1):333 [PubMed]
• Roos Eva A translational approach towards perihilar cholangiocarcinoma 2019. 339p. ISBN 9789463753364. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Gulik Thomas M., van de Vijver Marc J.; Co-supervisors: Verheij J. , van Hooft J. E.)
• Kumar Rakesh, van de Vijver Marc, Tortora Giampaolo, Ciardiello Fortunato, Goldkorn Tzipora, Miller Wilson H., Norton Larry A tribute to John Mendelsohn: A pioneer in targeted cancer therapy Cancer research 2019;79 (17):4315-4323 [PubMed]
• Nederlof Iris, de Bortoli Davide, Bareche Yacine, Nguyen Bastien, de Maaker Michiel, Hooijer Gerrit K. J., Buisseret Laurence, Kok Marleen, Smid Marcel, van den Eynden Gert G. G. M., Brinkman Arie B., Hudecek Jan, Koster Jan, Sotiriou Christos, Larsimont Denis, Martens John W. M., van de Vijver Marc J., Horlings Hugo M., Salgado Roberto, Biganzoli Elia, Desmedt Christine Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer Breast cancer research 2019;21 (1) [PubMed]
• Wijmans Lizzy, Baas Paul, Sieburgh Thomas E., de Bruin Daniel M., Ghuijs Petra M., van de Vijver Marc J., Bonta Peter I., Annema Jouke T. Confocal Laser Endomicroscopy as a Guidance Tool for Pleural Biopsies in Malignant Pleural Mesothelioma Chest 2019;156 (4):754-763 [PubMed]
• Nik-Zainal Serena, Davies Helen, Staaf Johan, Ramakrishna Manasa, Glodzik Dominik, Zou Xueqing, Martincorena Inigo, Alexandrov Ludmil B., Martin Sancha, Wedge David C., van Loo Peter, Ju Young Seok, Smid Marcel, Brinkman Arie B., Morganella Sandro, Aure Miriam R., Lingjærde Ole Christian, Langerød Anita, Ringnér Markus, Ahn Sung-Min, Boyault Sandrine, Brock Jane E., Broeks Annegien, Butler Adam, Desmedt Christine, Dirix Luc, Dronov Serge, Fatima Aquila, Foekens John A., Gerstung Moritz, Hooijer Gerrit K. J., Jang Se Jin, Jones David R., Kim Hyung-Yong, King Tari A., Krishnamurthy Savitri, Lee Hee Jin, Lee Jeong-Yeon, Li Yilong, McLaren Stuart, Menzies Andrew, Mustonen Ville, O’Meara Sarah, Pauporté Iris, Pivot Xavier, Purdie Colin A., Raine Keiran, Ramakrishnan Kamna, Rodríguez-González F. Germán, Romieu Gilles, Sieuwerts Anieta M., Simpson Peter T., Shepherd Rebecca, Stebbings Lucy, Stefansson Olafur A., Teague Jon, Tommasi Stefania, Treilleux Isabelle, van den Eynden Gert G., Vermeulen Peter, Vincent-Salomon Anne, Yates Lucy, Caldas Carlos, van’t Veer Laura, Tutt Andrew, Knappskog Stian, Tan Benita Kiat Tee, Jonkers Jos, Borg Åke, Ueno Naoto T., Sotiriou Christos, Viari Alain, Futreal P. Andrew, Campbell Peter J., Span Paul N., van Laere Steven, Lakhani Sunil R., Eyfjord Jorunn E., Thompson Alastair M., Birney Ewan, Stunnenberg Hendrik G., van de Vijver Marc J., Martens John W. M., Børresen-Dale Anne-Lise, Richardson Andrea L., Kong Gu, Thomas Gilles, Stratton Michael R. Correction to: Landscape of somatic mutations in 560 breast cancer whole-genome sequences (Nature, (2016), 534, 7605, (47-54), 10.1038/nature17676) Nature 2019;566 (7742):E1 [PubMed]
• Roos E., Soer E. C., Klompmaker S., Meijer L. L., Besselink M. G., Giovannetti E., Heger M., Kazemier G., Klümpen H. J., Takkenberg R. B., Wilmink H., Würdinger T., Dijk F., van Gulik T. M., Verheij J., van de Vijver M. J. Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract Critical reviews in oncology/hematology 2019;140:8-16 [PubMed]
• Savci-Heijink C. D., Halfwerk H., Hooijer G. K. J., Koster J., Horlings H. M., Meijer S. L., van de Vijver M. J. Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior Breast cancer research and treatment 2019;174 (3):649-659 [PubMed]
• Savcı Heijink C. D. Genomic characteristics of metastatic breast cancer 2019. 183p. ISBN 9789402812978. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van de Vijver Marc J., Horlings H. M.)
• van Hilst Jony, de Rooij Thijs, Bosscha Koop, Brinkman David J., van Dieren Susan, Dijkgraaf Marcel G., Gerhards Michael F., de Hingh Ignace H., Karsten Tom M., Lips Daniel J., Luyer Misha D., Busch Olivier R., Festen Sebastiaan, Besselink Marc G., Marsman Hendrik A., van Gulik Thomas M., Wicherts Dennis A., Eshuis Wietse J., Stibbe Luna A., Nieveen van Dijkum Els J. M., van Hooft Janine E., Fockens Paul, van Laarhoven Hanneke W., Wilmink Johanna W., van de Vijver Marcel J., Bijlsma Maarten F., Verheij Joanne, Nio C. Yung, van Lienden Krijn P., van Tienhoven Geertjan, Schoorlemmer Annuska, Creemers Geert-Jan, van Eijck Casper H. J., Groot Koerkamp Bas, Bruno Marco J., Eskens Ferry, Nuyttens Joost J., Pek Chulja, van der Schelling George P., Swijnenburg Rutger J., Brosens Lodewijk A., Roos Daphne, van Santvoort Hjalmar C., Haj Mohammad Nadia, Daams Freek, van Rijssen L. Bengt, van Veldhuisen Eran, Scholten Lianne, Strijker Marin, Korrel Maarten Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial lancet. Gastroenterology & hepatology 2019;4 (3):199-207 [PubMed]
• Roos Eva, Franken Lotte C., Soer Eline C., van Hooft Jeanin E., Takkenberg R. Bart, Klümpen Heinz-Josef, Wilmink Johanna W., van de Vijver Marc J., van Gulik Thomas M., Verheij Joanne Lost in translation: confusion on resection and dissection planes hampers the interpretation of pathology reports for perihilar cholangiocarcinoma Virchows Archiv 2019;475 (4):435-443 [PubMed]
• Butter Rogier, Hart't Nils A., Hooijer Gerrit K. J., Monkhorst Kim, Speel Ernst-Jan, Theunissen Paul, Thunnissen Erik, von der Thüsen Jan H., Timens Wim, van de Vijver Marc J. Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer Journal of clinical pathology 2019 [PubMed]
• Brinkman Arie B., Nik-Zainal Serena, Simmer Femke, Rodríguez-González F. Germán, Smid Marcel, Alexandrov Ludmil B., Butler Adam, Martin Sancha, Davies Helen, Glodzik Dominik, Zou Xueqing, Ramakrishna Manasa, Staaf Johan, Ringnér Markus, Sieuwerts Anieta, Ferrari Anthony, Morganella Sandro, Fleischer Thomas, Kristensen Vessela, Gut Marta, van de Vijver Marc J., Børresen-Dale Anne-Lise, Richardson Andrea L., Thomas Gilles, Gut Ivo G., Martens John W. M., Foekens John A., Stratton Michael R., Stunnenberg Hendrik G. Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation Nature communications 2019;10 (1) [PubMed]
• Belkouz Ali, Labeur Tim A., Dierks Joeri, Dijk Frederike, van Oijen Martijn G. H., Verheij Joanne, van Gulik Thomas M., van de Vijver Marc J., Wilmink Hanneke, Punt Cornelis J. A., Klümpen Heinz-Josef Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis Critical reviews in oncology/hematology 2019;141:82-94 [PubMed]
• de Boer Peter, Spijkerboer Anje M., Bleeker Maaike C. G., van Lonkhuijzen Luc R. C. W., Monraats M. lanie A., Nederveen Aart J., van de Vijver Marc J., Kenter Gemma G., Bel Arjan, Rasch Coen R. N., Stoker Jaap, Stalpers Lukas J. A. Prospective validation of craniocaudal tumour size on MR imaging compared to histoPAthology in patients with uterine cervical cancer: The MPAC study Clinical and Translational Radiation Oncology 2019;18:9-15 [PubMed]
• Smid Marcel, Wilting Saskia M., Uhr Katharina, Rodríguez-González F. Germán, de Weerd Vanja, Prager-van der Smissen Wendy J. C., van der Vlugt-Daane Michelle, van Galen Anne, Nik-Zainal Serena, Butler Adam, Martin Sancha, Davies Helen R., Staaf Johan, van de Vijver Marc J., Richardson Andrea L., MacGrogan Gaëten, Salgado Roberto, van den Eynden Gert G. G. M., Purdie Colin A., Thompson Alastair M., Caldas Carlos, Span Paul N., Sweep Fred C. G. J., Simpson Peter T., Lakhani Sunil R., van Laere Steven, Desmedt Christine, Paradiso Angelo, Eyfjord Jorunn, Broeks Annegien, Vincent-Salomon Anne, Futreal Andrew P., Knappskog Stian, King Tari, Viari Alain, Børresen-Dale Anne-Lise, Stunnenberg Hendrik G., Stratton Mike, Foekens John A., Sieuwerts Anieta M., Martens John W. M. The circular RNome of primary breast cancer Genome research 2019;29 (3):356-366 [PubMed]

2018

• Veenstra V. L., Damhofer H., Waasdorp C., van Rijssen L. B., van de Vijver M. J., Dijk F., Wilmink H. W., Besselink M. G., Busch O. R., Chang D. K., Bailey P. J., Biankin A. V., Kocher H. M., Medema J. P., Li J. S., Jiang R., Pierce D. W., van Laarhoven H. W. M., Bijlsma M. F. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy Oncogenesis 2018;7 (11) [PubMed]
• Sobral-Leite Marcelo, van de Vijver Koen, Michaut Magali, van der Linden Rianne, Hooijer Gerrit K. J., Horlings Hugo M., Severson Tesa M., Mulligan Anna Marie, Weerasooriya Nayana, Sanders Joyce, Glas Annuska M., Wehkamp Diederik, Mittempergher Lorenza, Kersten Kelly, Cimino-Mathews Ashley, Peters Dennis, Hooijberg Erik, Broeks Annegien, van de Vijver Marc J., Bernards Rene, Andrulis Irene L., Kok Marleen, de Visser Karin E., Schmidt Marjanka K. Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival Oncoimmunology 2018;7 (12) [PubMed]
• Teepen Jop C., Kok Judith L., van Leeuwen Flora E., Tissing Wim J. E., Dolsma Wil V., van der Pal Helena J., Loonen Jacqueline J., Bresters Dorine, Versluys Birgitta, van den Heuvel-Eibrink Marry M., van Dulmen-den Broeder Eline, van den Berg Marleen H., van der Heiden-van der Loo Margriet, Hauptmann Michael, Jongmans Marjolijn C., Overbeek Lucy I., van de Vijver Marc J., Kremer Leontien C. M., Ronckers Cecile M. Colorectal adenomas and cancers after childhood cancer treatment: A DCOG-LATER record linkage study Journal of the National Cancer Institute 2018;110 (7):758-767 [PubMed]
• Soer Eline, Brosens Lodewijk, van de Vijver Marc, Dijk Frederike, van Velthuysen Marie-Louise, Farina-Sarasqueta Arantza, Morreau Hans, Offerhaus Johan, Koens Lianne, Verheij Joanne Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens: An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens Virchows Archiv 2018;472 (4):533-543 [PubMed]

2017

• Glodzik Dominik, Morganella Sandro, Davies Helen, Simpson Peter T., Li Yilong, Zou Xueqing, Diez-Perez Javier, Staaf Johan, Alexandrov Ludmil B., Smid Marcel, Brinkman Arie B., Rye Inga Hansine, Russnes Hege, Raine Keiran, Purdie Colin A., Lakhani Sunil R., Thompson Alastair M., Birney Ewan, Stunnenberg Hendrik G., van de Vijver Marc J., Martens John W. M., Børresen-Dale Anne-Lise, Richardson Andrea L., Kong Gu, Viari Alain, Easton Douglas, Evan Gerard, Campbell Peter J., Stratton Michael R., Nik-Zainal Serena A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers Nature genetics 2017;49 (3):341-348 [PubMed]
• Savci-Heijink Cemile Dilara, Halfwerk Hans, Koster Jan, van de Vijver Marc Joan Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer BMC cancer 2017;17 (1):755 [PubMed]
• Creemers A., Krausz S., Strijker M., van der Wel M. J., Soer E. C., Reinten R. J., Besselink M. G., Wilmink J. W., van de Vijver M. J., van Noesel C. J. M., Verheij J., Meijer S. L., Dijk F., Bijlsma M. F., van Oijen M. G. H., van Laarhoven H. W. M. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS 2017;1868 (2):394-403 [PubMed]
• Glodzik Dominik, Morganella Sandro, Davies Helen, Simpson Peter T., Li Yilong, Zou Xueqing, Diez-Perez Javier, Staaf Johan, Alexandrov Ludmil B., Smid Marcel, Brinkman Arie B., Rye Inga Hansine, Russnes Hege, Raine Keiran, Purdie Colin A., Lakhani Sunil R., Thompson Alastair M., Birney Ewan, Stunnenberg Hendrik G., van de Vijver Marc J., Martens John W. M., Børresen-Dale Anne-Lise, Richardson Andrea L., Kong Gu, Viari Alain, Easton Douglas, Evan Gerard, Campbell Peter J., Stratton Michael R., Nik-Zainal Serena Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers Nature genetics 2017;49 (11):1661 [PubMed]
• Smeenge Martijn, Tranquart François, Mannaerts Christophe K., de Reijke Theo M., van de Vijver Marc J., Laguna M. Pilar, Pochon Sibylle, de La Rosette Jean J. M. C. H., Wijkstra Hessel First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study Investigative radiology 2017;52 (7):419-427 [PubMed]
• Davies Helen, Glodzik Dominik, Morganella Sandro, Yates Lucy R., Staaf Johan, Zou Xueqing, Ramakrishna Manasa, Martin Sancha, Boyault Sandrine, Sieuwerts Anieta M., Simpson Peter T., King Tari A., Raine Keiran, Eyfjord Jorunn E., Kong Gu, Borg Åke, Birney Ewan, Stunnenberg Hendrik G., van de Vijver Marc J., Børresen-Dale Anne-Lise, Martens John W. M., Span Paul N., Lakhani Sunil R., Vincent-Salomon Anne, Sotiriou Christos, Tutt Andrew, Thompson Alastair M., van Laere Steven, Richardson Andrea L., Viari Alain, Campbell Peter J., Stratton Michael R., Nik-Zainal Serena HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures Nature medicine 2017;23 (4):517-+ [PubMed]
• van der Leij Femke Optimizing treatment of low risk breast cancer patients 2017. 163p. ISBN 9789462336889. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van de Vijver M. J.; Co-supervisors: Elkhuizen P. H. M., Bartelink H.)
• Ju Young Seok, Martincorena Inigo, Gerstung Moritz, Petljak Mia, Alexandrov Ludmil B., Rahbari Raheleh, Wedge David C., Davies Helen R., Ramakrishna Manasa, Fullam Anthony, Martin Sancha, Alder Christopher, Patel Nikita, Gamble Steve, O'Meara Sarah, Giri Dilip D., Sauer Torril, Pinder Sarah E., Purdie Colin A., Borg Åke, Stunnenberg Henk, van de Vijver Marc, Tan Benita K. T., Caldas Carlos, Tutt Andrew, Ueno Naoto T., van 't Veer Laura J., Martens John W. M., Sotiriou Christos, Knappskog Stian, Span Paul N., Lakhani Sunil R., Eyfjörd Jórunn Erla, Børresen-Dale Anne-Lise, Richardson Andrea, Thompson Alastair M., Viari Alain, Hurles Matthew E., Nik-Zainal Serena, Campbell Peter J., Stratton Michael R. Somatic mutations reveal asymmetric cellular dynamics in the early human embryo Nature 2017;543 (7647):714-718 [PubMed]

2016

• Savci-Heijink C. Dilara, Halfwerk Hans, Koster Jan, van de Vijver Marc J. A novel gene expression signature for bone metastasis in breast carcinomas Breast cancer research and treatment 2016;156 (2):249-259 [PubMed]
• Smid Marcel, Rodríguez-González F. Germán, Sieuwerts Anieta M., Salgado Roberto, Prager-van der Smissen Wendy J. C., van der Vlugt-Daane Michelle, van Galen Anne, Nik-Zainal Serena, Staaf Johan, Brinkman Arie B., van de Vijver Marc J., Richardson Andrea L., Fatima Aquila, Berentsen Kim, Butler Adam, Martin Sancha, Davies Helen R., Debets Reno, Meijer-van Gelder Marion E., van Deurzen Carolien H. M., MacGrogan Gaëtan, van den Eynden Gert G. G. M., Purdie Colin, Thompson Alastair M., Caldas Carlos, Span Paul N., Simpson Peter T., Lakhani Sunil R., van Laere Steven, Desmedt Christine, Ringnér Markus, Tommasi Stefania, Eyford Jorunn, Broeks Annegien, Vincent-Salomon Anne, Futreal P. Andrew, Knappskog Stian, King Tari, Thomas Gilles, Viari Alain, Langerød Anita, Børresen-Dale Anne-Lise, Birney Ewan, Stunnenberg Hendrik G., Stratton Mike, Foekens John A., Martens John W. M. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration Nature communications 2016;7:12910 [PubMed]
• Tutein Nolthenius Charlotte J., Boellaard Thierry N., de Haan Margriet C., Nio C. Yung, Thomeer Maarten G. J., Bipat Shandra, Montauban van Swijndregt Alexander D., van de Vijver Marc J., Biermann Katharina, Kuipers Ernst J., Dekker Evelien, Stoker Jaap Computer tomography colonography participation and yield in patients under surveillance for 6-9 mm polyps in a population-based screening trial European radiology 2016;26 (8):2762-2770 [PubMed]
• IJspeert J. E. G., Tutein Nolthenius C. J., Kuipers E. J., van Leerdam M. E., Nio C. Y., Thomeer M. G. J., Biermann K., van de Vijver M. J., Dekker E., Stoker J. CT-Colonography vs. Colonoscopy for Detection of High-Risk Sessile Serrated Polyps American journal of gastroenterology 2016;111 (4):516-522 [PubMed]
• She Qing-Bai, Gruvberger-Saal Sofia K., Maurer Matthew, Chen Yilun, Jumppanen Mervi, Su Tao, Dendy Meaghan, Lau Ying-Ka Ingar, Memeo Lorenzo, Horlings Hugo M., van de Vijver Marc J., Isola Jorma, Hibshoosh Hanina, Rosen Neal, Parsons Ramon, Saal Lao H. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer BMC cancer 2016;16 (1):587 [PubMed]
• Nik-Zainal Serena, Davies Helen, Staaf Johan, Ramakrishna Manasa, Glodzik Dominik, Zou Xueqing, Martincorena Inigo, Alexandrov Ludmil B., Martin Sancha, Wedge David C., van Loo Peter, Ju Young Seok, Smid Marcel, Brinkman Arie B., Morganella Sandro, Aure Miriam R., Lingjærde Ole Christian, Langerød Anita, Ringnér Markus, Ahn Sung-Min, Boyault Sandrine, Brock Jane E., Broeks Annegien, Butler Adam, Desmedt Christine, Dirix Luc, Dronov Serge, Fatima Aquila, Foekens John A., Gerstung Moritz, Hooijer Gerrit K. J., Jang Se Jin, Jones David R., Kim Hyung-Yong, King Tari A., Krishnamurthy Savitri, Lee Hee Jin, Lee Jeong-Yeon, Li Yilong, McLaren Stuart, Menzies Andrew, Mustonen Ville, O'Meara Sarah, Pauporté Iris, Pivot Xavier, Purdie Colin A., Raine Keiran, Ramakrishnan Kamna, Rodríguez-González F. Germán, Romieu Gilles, Sieuwerts Anieta M., Simpson Peter T., Shepherd Rebecca, Stebbings Lucy, Stefansson Olafur A., Teague Jon, Tommasi Stefania, Treilleux Isabelle, van den Eynden Gert G., Vermeulen Peter, Vincent-Salomon Anne, Yates Lucy, Caldas Carlos, van't Veer Laura, Tutt Andrew, Knappskog Stian, Tan Benita Kiat Tee, Jonkers Jos, Borg Åke, Ueno Naoto T., Sotiriou Christos, Viari Alain, Futreal P. Andrew, Campbell Peter J., Span Paul N., van Laere Steven, Lakhani Sunil R., Eyfjord Jorunn E., Thompson Alastair M., Birney Ewan, Stunnenberg Hendrik G., van de Vijver Marc J., Martens John W. M., Børresen-Dale Anne-Lise, Richardson Andrea L., Kong Gu, Thomas Gilles, Stratton Michael R. Landscape of somatic mutations in 560 breast cancer whole-genome sequences Nature 2016;534 (7605):47-+ [PubMed]
• van der Leij Femke, van Werkhoven Erik, Bosma Sophie, Linn Sabine C., Rutgers Emiel J., van de Vijver Marc J., Bartelink Harry, Elkhuizen Paula H. M., Scholten Astrid Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute Breast (Edinburgh, Scotland) 2016;30:19-25 [PubMed]
• McConechy Melissa K., Färkkilä Anniina, Horlings Hugo M., Talhouk Aline, Unkila-Kallio Leila, van Meurs Hannah S., Yang Winnie, Rozenberg Nirit, Andersson Noora, Zaby Katharina, Bryk Saara, Bützow Ralf, Halfwerk Johannes B. G., Hooijer Gerrit K. J., van de Vijver Marc J., Buist Marrije R., Kenter Gemma G., Brucker Sara Y., Krämer Bernhard, Staebler Annette, Bleeker Maaike C. G., Heikinheimo Markku, Kommoss Stefan, Blake Gilks C., Anttonen Mikko, Huntsman David G. Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype Journal of the National Cancer Institute 2016;108 (11):djw134 [PubMed]
• Chen Yilun, van de Vijver Marc J., Hibshoosh Hanina, Parsons Ramon, Saal Lao H. PTEN and NEDD4 in Human Breast Carcinoma Pathology oncology research 2016;22 (1):41-47 [PubMed]
• van Rijssen Lennart B., Rombouts Steffi J. E., Walma Marieke S., Vogel Jantien A., Tol Johanna A., Molenaar Isaac Q., van Eijck Casper H. J., Verheij Joanne, van de Vijver Marc J., Busch Olivier R. C., Besselink Marc G. H. Recent Advances in Pancreatic Cancer Surgery of Relevance to the Practicing Pathologist Surgical pathology clinics 2016;9 (4):539-545 [PubMed]
• Morganella Sandro, Alexandrov Ludmil B., Glodzik Dominik, Zou Xueqing, Davies Helen, Staaf Johan, Sieuwerts Anieta M., Brinkman Arie B., Martin Sancha, Ramakrishna Manasa, Butler Adam, Kim Hyung-Yong, Borg Åke, Sotiriou Christos, Futreal P. Andrew, Campbell Peter J., Span Paul N., van Laere Steven, Lakhani Sunil R., Eyfjord Jorunn E., Thompson Alastair M., Stunnenberg Hendrik G., van de Vijver Marc J., Martens John W. M., Børresen-Dale Anne-Lise, Richardson Andrea L., Kong Gu, Thomas Gilles, Sale Julian, Rada Cristina, Stratton Michael R., Birney Ewan, Nik-Zainal Serena The topography of mutational processes in breast cancer genomes Nature communications 2016;7:11383 [PubMed]
• Bosma S. C. J., van der Leij F., van Werkhoven E., Bartelink H., Wesseling J., Linn S., Rutgers E. J., van de Vijver M. J., Elkhuizen P. H. M. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period Breast cancer research and treatment 2016;156 (2):391-400 [PubMed]

2015

• Damhofer Helene, Ebbing Eva A., Steins Anne, Welling Lieke, Tol Johanna A., Krishnadath Kausilia K., van Leusden Tom, van de Vijver Marc J., Besselink Marc G., Busch Olivier R., van Berge Henegouwen Mark I., van Delden Otto, Meijer Sybren L., Dijk Frederike, Medema Jan Paul, van Laarhoven Hanneke W., Bijlsma Maarten F. Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract Journal of translational medicine 2015;13 (1):115 [PubMed]
• Tutein Nolthenius Charlotte J., Boellaard Thierry N., de Haan Margriet C., Nio C. Yung, Thomeer Maarten G. J., Bipat Shandra, Montauban van Swijndregt Alexander D., van de Vijver Marc J., Biermann Katharina, Kuipers Ernst J., Dekker Evelien, Stoker Jaap Evolution of Screen-Detected Small (6-9 mm) Polyps After a 3-Year Surveillance Interval: Assessment of Growth With CT Colonography Compared With Histopathology American journal of gastroenterology 2015;110 (12):1682-1690 [PubMed]
• van der Leij Femke, Bosma Sophie C. J., van de Vijver Marc J., Wesseling Jelle, Vreeswijk Sandra, Rivera Sofia, Bourgier Celine, Garbay Jean-Rémi, Foukakis Theodoros, Lekberg Tobias, van den Bongard Desiree H. J. G. D., van Vliet-Vroegindeweij Corine, Bartelink Harry, Rutgers Emiel J., Elkhuizen Paula H. M. First results of the preoperative accelerated partial breast irradiation (PAPBI) trial Radiotherapy and oncology 2015;114 (3):322-327 [PubMed]
• Tan Puay Hoon, Schnitt Stuart J., van de Vijver Marc J., Ellis Ian O., Lakhani Sunil R. Papillary and neuroendocrine breast lesions: the WHO stance Histopathology 2015;66 (6):761-770 [PubMed]
• Rutten Marianne Jetske Predictive factors in epithelial ovarian cancer: Towards individualized patient care 2015. 198p. ISBN 9789462596610. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kenter G. G., van de Vijver M. J.; Co-supervisor: Buist M. R.)
• Dekker T. J. A., ter Borg S., Hooijer G. K. J., Meijer S. L., Wesseling J., Boers J. E., Schuuring E., Bart J., van Gorp J., Bult P., Riemersma S. A., van Deurzen C. H. M., Sleddens H. F. B. M., Mesker W. E., Kroep J. R., Smit V. T. H. B. M., van de Vijver M. J. Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach Breast cancer research and treatment 2015;152 (2):247-252 [PubMed]
• Dekker T. J. A., ter Borg S., Hooijer G. K. J., Meijer S. L., Wesseling J., Boers J. E., Schuuring E., Bart J., van Gorp J., Bult P., Riemersma S. A., van Deurzen C. H. M., Sleddens H. F. B. M., Mesker W. E., Kroep J. R., Smit V. T. H. B. M., van de Vijver M. J. Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach (vol 152, pg 247, 2015) Breast cancer research and treatment 2015;152 (2):253 [PubMed]
• Savci-Heijink C. Dilara, Halfwerk Hans, Hooijer Gerrit K. J., Horlings Hugo M., Wesseling Jelle, van de Vijver Marc J. Retrospective analysis of metastatic behaviour of breast cancer subtypes Breast cancer research and treatment 2015;150 (3):547-557 [PubMed]

2014

• Tubio Jose M. C., Li Yilong, Ju Young Seok, Martincorena Inigo, Cooke Susanna L., Tojo Marta, Gundem Gunes, Pipinikas Christodoulos P., Zamora Jorge, Raine Keiran, Menzies Andrew, Roman-Garcia Pablo, Fullam Anthony, Gerstung Moritz, Shlien Adam, Tarpey Patrick S., Papaemmanuil Elli, Knappskog Stian, van Loo Peter, Ramakrishna Manasa, Davies Helen R., Marshall John, Wedge David C., Teague Jon W., Butler Adam P., Nik-Zainal Serena, Alexandrov Ludmil, Behjati Sam, Yates Lucy R., Bolli Niccolo, Mudie Laura, Hardy Claire, Martin Sancha, McLaren Stuart, O'Meara Sarah, Anderson Elizabeth, Maddison Mark, Gamble Stephen, Foster Christopher, Warren Anne Y., Whitaker Hayley, Brewer Daniel, Eeles Rosalind, Cooper Colin, Neal David, Lynch Andy G., Visakorpi Tapio, Isaacs William B., van de Vijver Marc, Hooijer Gerrit K. J. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes Science 2014;345 (6196):531-+ [PubMed]
• Moelans Cathy B., van der Groep Petra, Hoefnagel Laurien D. C., van de Vijver Marc J., Wesseling Pieter, Wesseling Jelle, van der Wall Elsken, van Diest Paul J. Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes Cancer letters 2014;344 (1):138-146 [PubMed]
• Vollebergh Marieke A., Lips Esther H., Nederlof Petra M., Wessels Lodewyk F. A., Wesseling Jelle, Vd Vijver Marc J., de Vries Elisabeth G. E., van Tinteren Harm, Jonkers Jos, Hauptmann Michael, Rodenhuis Sjoerd, Linn Sabine C. Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy Breast cancer research 2014;16 (3):R47 [PubMed]
• Hanna Wedad M., Rüschoff Josef, Bilous Michael, Coudry Renata A., Dowsett Mitch, Osamura Robert Y., Penault-Llorca Frédérique, van de Vijver Marc, Viale Giuseppe HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity Modern pathology 2014;27 (1):4-18 [PubMed]
• Rutten M. J., Dijk F., Savci-Heijink C. D., Buist M. R., Kenter G. G., van de Vijver M. J., Jordanova E. S. HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas Journal of immunology research 2014;2014:274584 [PubMed]
• Farazi Thalia A., ten Hoeve Jelle J., Brown Miguel, Mihailovic Aleksandra, Horlings Hugo M., van de Vijver Marc J., Tuschl Thomas, Wessels Lodewyk F. A. Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets Genome biology 2014;15 (1):R9 [PubMed]
• Shiu K.-K., Wetterskog D., Mackay A., Natrajan R., Lambros M., Sims D., Bajrami I., Brough R., Frankum J., Sharpe R., Marchio C., Horlings H., Reyal F., van der Vijver M., Turner N., Reis-Filho J. S., Lord C. J., Ashworth A. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies Oncogene 2014;33 (5):619-631 [PubMed]
• Drukker C. A., van Tinteren H., Schmidt M. K., Rutgers E. J. Th, Bernards R., van de Vijver M. J., van't Veer L. J. Long-term impact of the 70-gene signature on breast cancer outcome Breast cancer research and treatment 2014;143 (3):587-592 [PubMed]
• van de Vijver Marc J. Molecular tests as prognostic factors in breast cancer Virchows Archiv 2014;464 (3):283-291 [PubMed]
• Drukker C. A., Nijenhuis M. V., Bueno-de-Mesquita J. M., Retèl V. P., van Harten W. H., van Tinteren H., Wesseling J., Schmidt M. K., van't Veer L. J., Sonke G. S., Rutgers E. J. T., van de Vijver M. J., Linn S. C. Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms Breast cancer research and treatment 2014;145 (3):697-705 [PubMed]
• Hazewinkel Yark, de Wijkerslooth Thomas R., Stoop Esther M., Bossuyt Patrick M., Biermann Katharina, van de Vijver Marc J., Fockens Paul, van Leerdam Monique E., Kuipers Ernst J., Dekker Evelien Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy Endoscopy 2014;46 (3):219-224 [PubMed]
• Cooke Susanna L., Shlien Adam, Marshall John, Pipinikas Christodoulos P., Martincorena Inigo, Tubio Jose M.C., Li Yilong, Menzies Andrew, Mudie Laura, Ramakrishna Manasa, Yates Lucy, Davies Helen, Bolli Niccolo, Bignell Graham R., Tarpey Patrick S., Behjati Sam, Nik-Zainal Serena, Papaemmanuil Elli, Teixeira Vitor H., Raine Keiran, Oameara Sarah, Dodoran Maryam S., Teague Jon W., Butler Adam P., Iacobuzio-Donahue Christine, Santarius Thomas, Grundy Richard G., Malkin David, Greaves Mel, Munshi Nikhil, Flanagan Adrienne M., Bowtell David, Martin Sancha, Larsimont Denis, Reis-Filho Jorge S., Boussioutas Alex, Taylor Jack A., Hayes Neil D., Janes Sam M., Futreal P. Andrew, Stratton Michael R., McDermott Ultan, Campbell Peter J., Provenzano Elena, van de Vijver Marc, Richardson Andrea L., Purdie Colin, Pinder Sarah, Grogan Gaetan Mac, Vincent-Salomon Anne, Larsimont Denis, Grabau Dorthe, Sauer Torill, Garred Øystein, Ehinger Anna, Van den Eynden Gert G., van Deurzen C. H.M., Salgado Roberto, Brock Jane E., Lakhani Sunil R., Giri Dilip D., Arnould Laurent, Jacquemier Jocelyne, Treilleux Isabelle, Caldas Carlos, Chin Suet Feung, Fatima Aquila, Thompson Alastair M., Stenhouse Alasdair, Foekens John, Martens John, Sieuwerts Anieta, Brinkman Arjen, Stunnenberg Henk, Span Paul N., Sweep Fred, Desmedt Christine, Sotiriou Christos, Thomas Gilles, Broeks Annegein, Langerod Anita, Aparicio Samuel, Simpson Peter T., van ’t Veer Laura, Eyfjord Jorunn Erla, Hilmarsdottir Holmfridur, Jonasson Jon G., Børresen-Dale Anne Lise, Ta Michael Lee Ming, Wong Bernice Huimin, Tee Tan Benita Kiat, Hooijer Gerrit K.J. Processed pseudogenes acquired somatically during cancer development Nature communications 2014;5 [PubMed]
• Jiwa Laura S., van Diest Paul J., Hoefnagel Laurien D., Wesseling Jelle, Wesseling Pieter, Moelans Cathy B., van de Vijver Marc J., van Slooten Henk-Jan, Westenend Pieter J., Bart Joost, Seldenrijk Cornelis A., Nagtegaal Iris D., Oudejans Joost, van der Valk Paul, van der Groep Petra, de Vries Elisabeth G. E., van der Wall Elsken Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases BMC cancer 2014;14:864 [PubMed]

2013

• Drukker C. A., Bueno-de-Mesquita J. M., Retèl V. P., van Harten W. H., van Tinteren H., Wesseling J., Roumen R. M. H., Knauer M., van 't Veer L. J., Sonke G. S., Rutgers E. J. T., van de Vijver M. J., Linn S. C. A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study International journal of cancer. Journal international du cancer 2013;133 (4):929-936 [PubMed]
• Hoefnagel L. D. C., van der Groep P., van de Vijver M. J., Boers J. E., Wesseling P., Wesseling J., van der Wall E., van Diest P. J. Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient Annals of oncology 2013;24 (12):3017-3023 [PubMed]
• Horlings Hugo M., Weigelt Britta, Anderson Eric M., Lambros Maryou B., Mackay Alan, Natrajan Rachael, Ng Charlotte K. Y., Geyer Felipe C., van de Vijver Marc J., Reis-Filho Jorge S. Genomic profiling of histological special types of breast cancer Breast cancer research and treatment 2013;142 (2):257-269 [PubMed]
• van der Bij Sjoukje, Baas Paul, van de Vijver Marc J., de Mol Bas A. J. M., Burgers Jacobus A. Legal claims for malignant mesothelioma: dealing with all cases Lung cancer (Amsterdam, Netherlands) 2013;80 (2):153-158 [PubMed]
• Dekker T. J. A., Smit V. T. H. B. M., Hooijer G. K. J., van de Vijver M. J., Mesker W. E., Tollenaar R. A. E. M., Nortier J. W. R., Kroep J. R. Reliability of core needle biopsy for determining ER and HER2 status in breast cancer Annals of oncology 2013;24 (4):931-937 [PubMed]
• de Boer Peter, Adam Judit A., Buist Marrije R., van de Vijver Marc J., Rasch Coen R., Stoker Jaap, Bipat Shandra, Stalpers Lukas J. A. Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: systematic review of diagnostic test accuracy European journal of radiology 2013;82 (9):e422-e428 [PubMed]
• Swank Hilko A., Mulder Irene M., Hop Wim C., van de Vijver Marc J., Lange Johan F., Bemelman Willem A. Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review Surgical endoscopy 2013;27 (12):4439-4448 [PubMed]

2012

• Dekker Tim J. A., Borg Susan Ter, Hooijer Gerrit K. J., Meijer Sybren L., Wesseling Jelle, Boers James E., Schuuring Ed, Bart Jos, van Gorp Joost, Mesker Wilma E., Kroep Judith R., Smit Vincent T. H. B. M., van de Vijver Marc J. Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach Breast cancer research 2012;14 (3):R93 [PubMed]
• Natrajan Rachael, Mackay Alan, Wilkerson Paul M., Lambros Maryou B., Wetterskog Daniel, Arnedos Monica, Shiu Kai-Keen, Geyer Felipe C., Langerød Anita, Kreike Bas, Reyal Fabien, Horlings Hugo M., van de Vijver Marc J., Palacios Jose, Weigelt Britta, Reis-Filho Jorge S. Functional characterization of the 19q12 amplicon in grade III breast cancers Breast cancer research 2012;14 (2):R53 [PubMed]
• Rüschoff Josef, Hanna Wedad, Bilous Michael, Hofmann Manfred, Osamura Robert Y., Penault-Llorca Frédérique, van de Vijver Marc, Viale Giuseppe HER2 testing in gastric cancer: a practical approach Modern pathology 2012;25 (5):637-650 [PubMed]
• van Vliet Martin H., Horlings Hugo M., van de Vijver Marc J., Reinders Marcel J. T., Wessels Lodewyk F. A. Integration of Clinical and Gene Expression Data Has a Synergetic Effect on Predicting Breast Cancer Outcome PLoS ONE 2012;7 (7):e40358 [PubMed]
• Tanis E., van de Velde C. J. H., Bartelink H., van de Vijver M. J., Putter H., van der Hage J. A. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer European journal of cancer (Oxford, England 2012;48 (12):1751-1756 [PubMed]
• Guiu S., Michiels S., André F., Cortes J., Denkert C., Di Leo A., Hennessy B. T., Sorlie T., Sotiriou C., Turner N., van de Vijver M., Viale G., Loi S., Reis-Filho J. S. Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement Annals of oncology 2012;23 (12):2997-3006 [PubMed]
• Stoop Esther M., de Haan Margriet C., de Wijkerslooth Thomas R., Bossuyt Patrick M., van Ballegooijen Marjolein, Nio C. Yung, van de Vijver Marc J., Biermann Katharina, Thomeer Maarten, van Leerdam Monique E., Fockens Paul, Stoker Jaap, Kuipers Ernst J., Dekker Evelien Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial lancet oncology 2012;13 (1):55-64 [PubMed]
• van der Leij Femke, Elkhuizen Paula H. M., Bartelink Harry, van de Vijver Marc J. Predictive Factors for Local Recurrence in Breast Cancer Seminars in radiation oncology 2012;22 (2):100-107 [PubMed]
• van der Bij S., Koffijberg H., Burgers J. A., Baas P., van de Vijver M. J., de Mol B. A. J. M., Moons K. G. M. Prognosis and prognostic factors of patients with mesothelioma: a population-based study British journal of cancer 2012;107 (1):161-164 [PubMed]
• Servant Nicolas, Bollet Marc A., Halfwerk Hans, Bleakley Kevin, Kreike Bas, Jacob Laurent, Sie Daoud, Kerkhoven Ron M., Hupé Philippe, Hadhri Rim, Fourquet Alain, Bartelink Harry, Barillot Emmanuel, Sigal-Zafrani Brigitte, van de Vijver Marc J. Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women Clinical cancer research 2012;18 (6):1704-1715 [PubMed]
• Stephens Philip J., Tarpey Patrick S., Davies Helen, van Loo Peter, Greenman Chris, Wedge David C., Nik-Zainal Serena, Martin Sancha, Varela Ignacio, Bignell Graham R., Yates Lucy R., Papaemmanuil Elli, Beare David, Butler Adam, Cheverton Angela, Gamble John, Hinton Jonathan, Jia Mingming, Jayakumar Alagu, Jones David, Latimer Calli, Lau King Wai, McLaren Stuart, McBride David J., Menzies Andrew, Mudie Laura, Raine Keiran, Rad Roland, Chapman Michael Spencer, Teague Jon, Easton Douglas, Langerød Anita, Lee Ming Ta Michael, Shen Chen-Yang, tee Benita Tan Kiat, Huimin Bernice Wong, Broeks Annegien, Vargas Ana Cristina, Turashvili Gulisa, Martens John, Fatima Aquila, Miron Penelope, Chin Suet-Feung, Thomas Gilles, Boyault Sandrine, Mariani Odette, Lakhani Sunil R., van de Vijver Marc, van 't Veer Laura, Foekens John The landscape of cancer genes and mutational processes in breast cancer Nature 2012;486 (7403):400-+ [PubMed]

2011

• Bueno-de-Mesquita J. M., Sonke G. S., van de Vijver M. J., Linn S. C. Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice Annals of oncology 2011;22 (9):2021-2030 [PubMed]
• Vollebergh M. A., Lips E. H., Nederlof P. M., Wessels L. F. A., Schmidt M. K., van Beers E. H., Cornelissen S., Holtkamp M., Froklage F. E., de Vries E. G. E., Schrama J. G., Wesseling J., van de Vijver M. J., van Tinteren H., de Bruin Michiel, Hauptmann M., Rodenhuis S., Linn S. C. An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients Annals of oncology 2011;22 (7):1561-1570 [PubMed]
• van Nes Johanna G. H., de Kruijf Esther M., Faratian Dana, van de Velde Cornelis J. H., Putter Hein, Falconer Claire, Smit Vincent T. H. B. M., Kay Charlene, van de Vijver Marc J., Kuppen Peter J. K., Bartlett John M. S. COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients Breast cancer research and treatment 2011;125 (3):671-685 [PubMed]
• Hartog Hermien, Horlings Hugo M., van der Vegt Bert, Kreike Bas, Ajouaou Abderrahim, van de Vijver Marc J., Marike Boezen H., de Bock Geertruida H., van der Graaf Winette T. A., Wesseling Jelle Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma Breast cancer research and treatment 2011;129 (3):725-736 [PubMed]
• Sanz-Pamplona Rebeca, Aragüés Ramón, Driouch Keltouma, Martín Berta, Oliva Baldo, Gil Miguel, Boluda Susana, Fernández Pedro L., Martínez Antonio, Moreno Víctor, Acebes Juan J., Lidereau Rosette, Reyal Fabien, van de Vijver Marc J., Sierra Angels Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors American journal of pathology 2011;179 (2):564-579 [PubMed]
• Hung Tiffany, Wang Yulei, Lin Michael F., Koegel Ashley K., Kotake Yojiro, Grant Gavin D., Horlings Hugo M., Shah Nilay, Umbricht Christopher, Wang Pei, Wang Yu, Kong Benjamin, Langerød Anita, Børresen-Dale Anne-Lise, Kim Seung K., van de Vijver Marc, Sukumar Saraswati, Whitfield Michael L., Kellis Manolis, Xiong Yue, Wong David J., Chang Howard Y. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters Nature genetics 2011;43 (7):621-629 [PubMed]
• Hajage David, de Rycke Yann, Bollet Marc, Savignoni Alexia, Caly Martial, Pierga Jean-Yves, Horlings Hugo M., van de Vijver Marc J., Vincent-Salomon Anne, Sigal-Zafrani Brigitte, Senechal Claire, Asselain Bernard, Sastre Xavier, Reyal Fabien External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement PLoS ONE 2011;6 (11):e27446 [PubMed]
• Kreike Bas Gene expression profiling of breast cancer to identify subtypes and to predict local recurrence after breast conserving therapy 2011. 121p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van de Vijver M. J., Bartelink G. M. M.)
• Meijer Sybren L., Wesseling Jelle, Smit Vincent T., Nederlof Petra M., Hooijer Gerrit K. J., Ruijter Henrique, Arends Jan Willem, Kliffen Mike, van Gorp Joost M., Sterk Lotus, van de Vijver Marc J. HER2 gene amplification in patients with breast cancer with equivocal IHC results Journal of clinical pathology 2011;64 (12):1069-1072 [PubMed]
• van der Hage Jos A., Mieog J. Sven D., van de Velde Cornelis J. H., Putter Hein, Bartelink Harry, van de Vijver Marc J. Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials Breast cancer research 2011;13 (3):R68 [PubMed]
• Horlings H. M. Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling 2011. 191p. ISBN 9789077713921. [UvA Dissertations Online] University of Amsterdam. (Supervisor: van de Vijver M. J.)
• van der Zaag E. S., Welling L., Peters H. M., van de Vijver M. J., Bemelman W. A., Buskens C. J. Indeling occulte tumorcellen in de lymfklieren bij patiënten met darmkanker onvoldoende betrouwbaar Nederlands tijdschrift voor geneeskunde 2011;155 (7):A2697 [PubMed]
• Lips E. H., Mulder L., Hannemann J., Laddach N., Vrancken Peeters M. T. F. D., van de Vijver M. J., Wesseling J., Nederlof P. M., Rodenhuis S. Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy Annals of oncology 2011;22 (4):870-876 [PubMed]
• Zonderland Harmien M., van de Vijver Marc J., Visser Mike Mammadiagnostiek: integratie pathologie en radiologie Nederlands tijdschrift voor geneeskunde 2011;155 (18):A2967 [PubMed]
• de Sousa E Melo Felipe, Colak Selcuk, Buikhuisen Joyce, Koster Jan, Cameron Kate, de Jong Joan H., Tuynman Jurriaan B., Prasetyanti Pramudita R., Fessler Evelyn, van den Bergh Saskia P., Rodermond Hans, Dekker Evelien, van der Loos Chris M., Pals Steven T., van de Vijver Marc J., Versteeg Rogier, Richel Dick J., Vermeulen Louis, Medema Jan Paul Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients Cell stem cell 2011;9 (5):476-485 [PubMed]
• Farazi Thalia A., Horlings Hugo M., ten Hoeve Jelle J., Mihailovic Aleksandra, Halfwerk Hans, Morozov Pavel, Brown Miguel, Hafner Markus, Reyal Fabien, van Kouwenhove Marieke, Kreike Bas, Sie Daoud, Hovestadt Volker, Wessels Lodewyk F. A., van de Vijver Marc J., Tuschl Thomas MicroRNA sequence and expression analysis in breast tumors by deep sequencing Cancer research 2011;71 (13):4443-4453 [PubMed]
• Beck Andrew H., Sangoi Ankur R., Leung Samuel, Marinelli Robert J., Nielsen Torsten O., van de Vijver Marc J., West Robert B., van de Rijn Matt, Koller Daphne Systematic analysis of breast cancer morphology uncovers stromal features associated with survival Science translational medicine 2011;3 (108):108ra113 [PubMed]

2010

• Kreike Bas, Hart Guus, Bartelink Harry, van de Vijver Marc J. Analysis of breast cancer related gene expression using natural splines and the Cox proportional hazard model to identify prognostic associations Breast cancer research and treatment 2010;122 (3):711-720 [PubMed]
• Rodenhuis S., Mandjes I. A. M., Wesseling J., van de Vijver M. J., Peeters M.-J. T. D. F. Vrancken, Sonke G. S., Linn S. C. A simple system for grading the response of breast cancer to neoadjuvant chemotherapy Annals of oncology 2010;21 (3):481-487 [PubMed]
• Holstege Henne, Horlings Hugo M., Velds Arno, Langerod Anita, Borresen-Dale Anne-Lise, van de Vijver Marc J., Nederlof Petra M., Jonkers Jos BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations BMC cancer 2010;10 (1):654 [PubMed]
• de Ronde Jorma J., Hannemann Juliane, Halfwerk Hans, Mulder Lennart, Straver Marieke E., Vrancken Peeters Marie-Jeanne T. F. D., Wesseling Jelle, van de Vijver Marc, Wessels Lodewyk F. A., Rodenhuis Sjoerd Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response Breast cancer research and treatment 2010;119 (1):119-126 [PubMed]
• van der Zaag E. S., Kooij N., van de Vijver M. J., Bemelman W. A., Peters H. M., Buskens C. J. Diagnosing occult tumour cells and their predictive value in sentinel nodes of histologically negative patients with colorectal cancer European journal of surgical oncology 2010;36 (4):350-357 [PubMed]
• Bilous Michael, Osamura Robert Y., Rüschoff J., van de Vijver Marc, Hanna Wedad, Penault-Llorca Frederique, Roche Patrick HER-2 amplification is highly homogenous in gastric cancer Human pathology 2010;41 (2):304-5; author reply 305-6 [PubMed]
• Nuyten Dimitry S. A. Hypothesis driven gene expression profiling in breast cancers.l: 2010. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van de Vijver M. J., Bartelink G. M. M.)
• Horlings Hugo M., Lai Carmen, Nuyten Dimitry S. A., Halfwerk Hans, Kristel Petra, van Beers Erik, Joosse Simon A., Klijn Christiaan, Nederlof Petra M., Reinders Marcel J. T., Wessels Lodewyk F. A., van de Vijver Marc J. Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients Clinical cancer research 2010;16 (2):651-663 [PubMed]
• Turner N., Lambros M. B., Horlings H. M., Pearson A., Sharpe R., Natrajan R., Geyer F. C., van Kouwenhove M., Kreike B., Mackay A., Ashworth A., van de Vijver M. J., Reis-Filho J. S. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets Oncogene 2010;29 (14):2013-2023 [PubMed]
• Hudson Thomas J., Anderson Warwick, Aretz Axel, Barker Anna D., Bell Cindy, Bernabé Rosa R., Bhan M. K., Calvo Fabien, Eerola Iiro, Gerhard Daniela S., Guttmacher Alan, Guyer Mark, Hemsley Fiona M., Jennings Jennifer L., Kerr David, Klatt Peter, Kolar Patrik, Kusuda Jun, Lane David P., Laplace Frank, Lu Youyong, Nettekoven Gerd, Ozenberger Brad, Peterson Jane, Rao T. S., Remacle Jacques, Schafer Alan J., Shibata Tatsuhiro, Stratton Michael R., Vockley Joseph G., Watanabe Koichi, Yang Huanming, Yuen Matthew M. F., Knoppers Bartha M., Bobrow Martin, Cambon-Thomsen Anne, Dressler Lynn G., Dyke Stephanie O. M., Joly Yann, Kato Kazuto, Kennedy Karen L., Nicolás Pilar, Parker Michael J., Rial-Sebbag Emmanuelle, Romeo-Casabona Carlos M., Shaw Kenna M., Wallace Susan, Wiesner Georgia L., Zeps Nikolajs, van de Vijver Marc International network of cancer genome projects Nature 2010;464 (7291):993-998 [PubMed]
• Gupta Rajnish A., Shah Nilay, Wang Kevin C., Kim Jeewon, Horlings Hugo M., Wong David J., Tsai Miao-Chih, Hung Tiffany, Argani Pedram, Rinn John L., Wang Yulei, Brzoska Pius, Kong Benjamin, Li Rui, West Robert B., van de Vijver Marc J., Sukumar Saraswati, Chang Howard Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis Nature 2010;464 (7291):1071-U148 [PubMed]
• Blamey R. W., Hornmark-Stenstam B., Ball G., Blichert-Toft M., Cataliotti L., Fourquet A., Gee J., Holli K., Jakesz R., Kerin M., Mansel R., Nicholson R., Pienkowski T., Pinder S., Sundquist M., van de Vijver M., Ellis I. ONCOPOOL - a European database for 16,944 cases of breast cancer European journal of cancer (Oxford, England 2010;46 (1):56-71 [PubMed]
• Broeks Annegien, Braaf Linde M., Wessels Lodewyk F. A., van de Vijver Marc, de Bruin Marie L., Stovall Marilyn, Russell Nicola S., van Leeuwen Flora E., van 't Veer Laura J. Radiation-associated breast tumors display a distinct gene expression profile International journal of radiation oncology, biology, physics 2010;76 (2):540-547 [PubMed]
• Hoefnagel Laurien D. C., van de Vijver Marc J., van Slooten Henk-Jan, Wesseling Pieter, Wesseling Jelle, Westenend Pieter J., Bart Joost, Seldenrijk Cornelis A., Nagtegaal Iris D., Oudejans Joost, van der Valk Paul, van der Groep Petra, de Vries Elisabeth G. E., van der Wall Elsken, van Diest Paul J. Receptor conversion in distant breast cancer metastases Breast cancer research 2010;12 (5):R75 [PubMed]
• Mook S., Schmidt M. K., Weigelt B., Kreike B., Eekhout I., van de Vijver M. J., Glas A. M., Floore A., Rutgers E. J. T., van 't Veer L. J. The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age Annals of oncology 2010;21 (4):717-722 [PubMed]
• Straver Marieke E., Glas Annuska M., Hannemann Juliane, Wesseling Jelle, van de Vijver Marc J., Rutgers Emiel J. Th, Vrancken Peeters Marie-Jeanne T. F. D., van Tinteren Harm, van't Veer Laura J., Rodenhuis Sjoerd The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer Breast cancer research and treatment 2010;119 (3):551-558 [PubMed]
• Bueno-de-Mesquita J. M., Nuyten D. S. A., Wesseling J., van Tinteren H., Linn S. C., van de Vijver M. J. The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment Annals of oncology 2010;21 (1):40-47 [PubMed]
• Knauer Michael, Mook Stella, Rutgers Emiel J. T., Bender Richard A., Hauptmann Michael, van de Vijver Marc J., Koornstra Rutger H. T., Bueno-de-Mesquita Jolien M., Linn Sabine C., van 't Veer Laura J. The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer Breast cancer research and treatment 2010;120 (3):655-661 [PubMed]
• Horlings Hugo M., Savci-Heijink C. Dilara, van de Vijver Marc J. Translating the Genomic Architecture of Breast Cancer into Clinical Applications Science translational medicine 2010;2 (38):38ps32 [PubMed]

2009

• Stein Torsten, Salomonis Nathan, Nuyten Dimitry S. A., van de Vijver Marc J., Gusterson Barry A. A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis Journal of mammary gland biology and neoplasia 2009;14 (2):99-116 [PubMed]
• Retèl Valesca P., Bueno-de-Mesquita Jolien M., Hummel Marjan J. M., van de Vijver Marc J., Douma Kirsten F. L., Karsenberg Kim, van Dam Frits S. A. M., van Krimpen Cees, Bellot Frank E., Roumen Rudi M. H., Linn Sabine C., van Harten Wim H. Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnostics International journal of technology assessment in health care 2009;25 (1):73-83 [PubMed]
• Penault-Llorca Frédérique, Bilous Michael, Dowsett Mitch, Hanna Wedad, Osamura Robert Yoshiyuki, Rüschoff Josef, van de Vijver Marc Emerging technologies for assessing HER2 amplification American journal of clinical pathology 2009;132 (4):539-548 [PubMed]
• Bos Paula D., Zhang Xiang H.-F., Nadal Cristina, Shu Weiping, Gomis Roger R., Nguyen Don X., Minn Andy J., van de Vijver Marc J., Gerald William L., Foekens John A., Massagué Joan Genes that mediate breast cancer metastasis to the brain Nature 2009;459 (7249):1005-U137 [PubMed]
• Liu G., Bollig-Fischer A., Kreike B., van de Vijver M. J., Abrams J., Ethier S. P., Yang Z.-Q. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer Oncogene 2009;28 (50):4491-4500 [PubMed]
• Kreike Bas, Halfwerk Hans, Armstrong Nicola, Bult Peter, Foekens John A., Veltkamp Sanne C., Nuyten Dimitry S. A., Bartelink Harry, van de Vijver Marc J. Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients Clinical cancer research 2009;15 (12):4181-4190 [PubMed]
• Roepman Paul, Horlings Hugo M., Krijgsman Oscar, Kok Marleen, Bueno-de-Mesquita Jolien M., Bender Richard, Linn Sabine C., Glas Annuska M., van de Vijver Marc J. Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast Cancer Clinical cancer research 2009;15 (22):7003-7011 [PubMed]
• Creighton Chad J., Kent Osborne C., van de Vijver Marc J., Foekens John A., Klijn Jan G., Horlings Hugo M., Nuyten Dimitry, Wang Yixin, Zhang Yi, Chamness Gary C., Hilsenbeck Susan G., Lee Adrian V., Schiff Rachel Molecular profiles of progesterone receptor loss in human breast tumors Breast cancer research and treatment 2009;114 (2):287-299 [PubMed]
• Russell Nicola S., Kunkler Ian H., van Tienhoven Geertjan, Canney Peter A., Thomas Jeremy, Bartlett John, van de Vijver Marc J., Belkacemi Yazid, Yarnold John R., Barrett-Lee Peter J. Postmastectomy Radiotherapy: Will the Selective Use of Postmastectomy Radiotherapy Study End the Debate? Journal of clinical oncology 2009;27 (6):996-997 [PubMed]
• van Nes Johanna G. H., Putter Hein, Julien Jean-Pierre, Tubiana-Hulin Michelle, van de Vijver Marc, Bogaerts Jan, de Vos Monika, van de Velde Cornelis J. H. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902 Breast cancer research and treatment 2009;115 (1):101-113 [PubMed]
• Wertheim Gerald B. W., Yang Thomas W., Pan Tien-Chi, Ramne Anna, Liu Zhandong, Gardner Heather P., Dugan Katherine D., Kristel Petra, Kreike Bas, van de Vijver Marc J., Cardiff Robert D., Reynolds Carol, Chodosh Lewis A. The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis Proceedings of the National Academy of Sciences of the United States of America 2009;106 (37):15855-15860 [PubMed]
• Bueno-de-Mesquita J. M., Linn S. C., Keijzer R., Wesseling J., Nuyten D. S. A., van Krimpen C., Meijers C., de Graaf P. W., Bos M. M. E. M., Hart A. A. M., Rutgers E. J. T., Peterse J. L., Halfwerk H., de Groot R., Pronk A., Floore A. N., Glas A. M., van't Veer L. J., van de Vijver M. J. Validation of 70-gene prognosis signature in node-negative breast cancer Breast cancer research and treatment 2009;117 (3):483-495 [PubMed]
• Leary Alexandra F., Hanna Wedad M., van de Vijver Marc J., Penault-Llorca Frederique, Rüschoff Josef, Osamura Robert Y., Bilous Michael, Dowsett Mitch Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients Journal of clinical oncology 2009;27 (10):1694-1705 [PubMed]
• Bueno-de-Mesquita Jolien M. Who needs adjuvant systematic treatment? Predicting prognosis in node-negative breast cancer; from bench to bedside 2009. 183p. ISBN 9789090242934. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van de Vijver M. J., Rodenhuis S.; Co-supervisor: Linn S. C.)

2008

• Reyal Fabien, van Vliet Martin H., Armstrong Nicola J., Horlings Hugo M., de Visser Karin E., Kok Marlen, Teschendorff Andrew E., Mook Stella, van 't Veer Laura, Caldas Carlos, Salmon Remy J., van de Vijver Marc J., Wessels Lodewyk F. A. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of Proliferation, Immune response and RNA splicing modules in breast cancer Breast cancer research 2008;10 (6):R93 [PubMed]
• Jongsma Johan, van Montfort Erwin, Vooijs Marc, Zevenhoven John, Krimpenfort Paul, van der Valk Martin, van de Vijver Marc, Berns Anton A conditional mouse model for malignant mesothelioma Cancer cell 2008;13 (3):261-271 [PubMed]
• Stemke-Hale Katherine, Gonzalez-Angulo Ana Maria, Lluch Ana, Neve Richard M., Kuo Wen-Lin, Davies Michael, Carey Mark, Hu Zhi, Guan Yinghui, Sahin Aysegul, Symmans W. Fraser, Pusztai Lajos, Nolden Laura K., Horlings Hugo, Berns Katrien, Hung Mien-Chie, van de Vijver Marc J., Valero Vicente, Gray Joe W., Bernards René, Mills Gordon B., Hennessy Bryan T. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer Cancer research 2008;68 (15):6084-6091 [PubMed]
• Weichselbaum Ralph R., Ishwaran Hemant, Yoon Taewon, Nuyten Dimitry S. A., Baker Samuel W., Khodarev Nikolai, Su Andy W., Shaikh Arif Y., Roach Paul, Kreike Bas, Roizman Bernard, Bergh Jonas, Pawitan Yudi, van de Vijver Marc J., Minn Andy J. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer Proceedings of the National Academy of Sciences of the United States of America 2008;105 (47):18490-18495 [PubMed]
• Linn Sabine C., Bueno-de-Mesquita Jolien M., van de Vijver Marc J. Are gene signatures better than traditional clinical factors? - Authors' reply lancet oncology 2008;9 (3):198-199 [PubMed]
• Hofmann M., Stoss O., Shi D., Büttner R., van de Vijver M., Kim W., Ochiai A., Rüschoff J., Henkel T. Assessment of a HER2 scoring system for gastric cancer: results from a validation study Histopathology 2008;52 (7):797-805 [PubMed]
• Nuyten Dimitry S. A., Hastie Trevor, Chi Jen-Tsan Ashley, Chang Howard Y., van de Vijver Marc J. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification European journal of cancer (Oxford, England 2008;44 (15):2319-2329 [PubMed]
• Kreike Bas, Hart Augustinus A. M., van de Velde Tony, Borger Jacques, Peterse Hans, Rutgers Emiel, Bartelink Harry, van de Vijver Marc J. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up International journal of radiation oncology, biology, physics 2008;71 (4):1014-1021 [PubMed]
• Loo Claudette E., Teertstra H. Jelle, Rodenhuis Sjoerd, van de Vijver Marc J., Hannemann Juliane, Muller Saar H., Peeters Marie-Jeanne Vrancken, Gilhuijs Kenneth G. A. Dynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: Initial Results AJR. American journal of roentgenology 2008;191 (5):1331-1338 [PubMed]
• Horlings Hugo M., Bergamaschi Anna, Nordgard Silje H., Kim Young H., Han Wonshik, Noh Dong-Young, Salari Keyan, Joosse Simon A., Reyal Fabien, Lingjaerde Ole Christian, Kristensen Vessela N., Børresen-Dale Anne-Lise, Pollack Jonathan, van de Vijver Marc J. ESR1 gene amplification in breast cancer: a common phenomenon? Nature genetics 2008;40 (7):807-8; author reply 810-2 [PubMed]
• Pietersen Alexandra M., Horlings Hugo M., Hauptmann Michael, Langerod Anita, Ajouaou Abderrahim, Cornelissen-Steijger Paulien, Wessels Lodewijk F., Jonkers Jos, van de Vijver Marc J., van Lohuizen Maarten EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer Breast cancer research 2008;10 (6):R109 [PubMed]
• Hannemann Juliane Gene expression profiling in breast cancer . A link between biology and clinical decision making 2008. 130p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van de Vijver M. J., Rodenhuis S.)
• Meijnen P., Peterse J. L., Antonini N., Rutgers E. J. Th, van de Vijver M. J. Immunohistochemical categorisation of ductal carcinoma in situ of the breast British journal of cancer 2008;98 (1):137-142 [PubMed]
• Riegman Peter H. J., Bosch Antonio Llombart, Riegman P. H. J., Dinjens W. N. M., Oomen M. H. A., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., Lopez-Guerrero J. A., Bosch A. Llombart, Carbone A., Gloghini A., Teodorovic I., Isabelle M., Jaminé D., Passioukov A., Lejeune S., Therasse P., van Veen E. B., Lam K. H., Oosterhuis J. W. OECI TuBaFrost tumor biobanking Tumori 2008;94 (2):160-163 [PubMed]
• van Vliet Martin H., Reyal Fabien, Horlings Hugo M., van de Vijver Marc J., Reinders Marcel J. T., Wessels Lodewyk F. A. Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability BMC genomics 2008;9 (1):375 [PubMed]
• Weigelt B., Horlings H. M., Kreike B., Hayes M. M., Hauptmann M., Wessels L. F. A., de Jong D., van de Vijver M. J., van't Veer L. J., Peterse J. L. Refinement of breast cancer classification by molecular characterization of histological special types Journal of pathology 2008;216 (2):141-150 [PubMed]
• Wong David J., Nuyten Dimitry S. A., Regev Aviv, Lin Meihong, Adler Adam S., Segal Eran, van de Vijver Marc J., Chang Howard Y. Revealing targeted therapy for human cancer by gene module maps Cancer research 2008;68 (2):369-378 [PubMed]
• Elkhuizen Paula H. M., Kreike Bas, van de Vijver Marc J. Risk factors for local recurrence following conservation therapy in breast cancerin: Prognostic and Predictive Factors in Breast Cancer. CRC Press; 2008. p. 38-52, ISBN 0415422256
• Starmans M. H. W., Krishnapuram B., Steck H., Horlings H., Nuyten D. S. A., van de Vijver M. J., Seigneuric R., Buffa F. M., Harris A. L., Wouters B. G., Lambin P. Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types British journal of cancer 2008;99 (11):1884-1890 [PubMed]
• Nuyten Dimitry S. A., van de Vijver Marc J. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity Seminars in radiation oncology 2008;18 (2):105-114 [PubMed]

2007

• Berns Katrien, Horlings Hugo M., Hennessy Bryan T., Madiredjo Mandy, Hijmans E. Marielle, Beelen Karin, Linn Sabine C., Gonzalez-Angulo Ana Maria, Stemke-Hale Katherine, Hauptmann Michael, Beijersbergen Roderick L., Mills Gordon B., van de Vijver Marc J., Bernards René A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer Cancer cell 2007;12 (4):395-402 [PubMed]
• Wolff Antonio C., Hammond M. Elizabeth H., Schwartz Jared N., Hagerty Karen L., Allred D. Craig, Cote Richard J., Dowsett Mitchell, Fitzgibbons Patrick L., Hanna Wedad M., Langer Amy, McShane Lisa M., Paik Soonmyung, Pegram Mark D., Perez Edith A., Press Michael F., Rhodes Anthony, Sturgeon Catharine, Taube Sheila E., Tubbs Raymond, Vance Gail H., van de Vijver Marc, Wheeler Thomas M., Hayes Daniel F. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Archives of pathology & laboratory medicine 2007;131 (1):18-43 [PubMed]
• Wolff Antonio C., Hammond M. Elizabeth H., Schwartz Jared N., Hagerty Karen L., Allred D. Craig, Cote Richard J., Dowsett Mitchell, Fitzgibbons Patrick L., Hanna Wedad M., Langer Amy, McShane Lisa M., Paik Soonmyung, Pegram Mark D., Perez Edith A., Press Michael F., Rhodes Anthony, Sturgeon Catharine, Taube Sheila E., Tubbs Raymond, Vance Gail H., van de Vijver Marc, Wheeler Thomas M., Hayes Daniel F. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Journal of clinical oncology 2007;25 (1):118-145 [PubMed]
• Kreike Bas, van de Vijver Marc J. Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response Breast cancer research 2007;9 (6):405 [PubMed]
• van de Vijver Marc J., Bilous Michael, Hanna Wedad, Hofmann Manfred, Kristel Petra, Penault-Llorca Frederique, Ruschoff Josef Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study Breast cancer research 2007;9 (5):R68 [PubMed]
• van Zandwijk N., van de Vijver M. J. Clairvoyance or reliable prediction of the future? Annals of oncology 2007;18 (3):407-408 [PubMed]
• van der Hage Jos A., Mieog J. Sven D., van de Vijver Marc J., van de Velde Cornelis J. H. Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis Breast cancer research 2007;9 (5):R70 [PubMed]
• Kreike Bas, van Kouwenhove Marieke, Horlings Hugo, Weigelt Britta, Peterse Hans, Bartelink Harry, van de Vijver Marc J. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Breast cancer research 2007;9 (5):R65 [PubMed]
• Chi Jen-Tsan, Rodriguez Edwin H., Wang Zhen, Nuyten Dimitry S. A., Mukherjee Sayan, van de Rijn Matt, van de Vijver Marc J., Hastie Trevor, Brown Patrick O. Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers PLoS genetics 2007;3 (9):1770-1784 [PubMed]
• Minn Andy J., Gupta Gaorav P., Padua David, Bos Paula, Nguyen Don X., Nuyten Dimitry, Kreike Bas, Zhang Yi, Wang Yixin, Ishwaran Hemant, Foekens John A., van de Vijver Marc, Massagué Joan Lung metastasis genes couple breast tumor size and metastatic spread Proceedings of the National Academy of Sciences of the United States of America 2007;104 (16):6740-6745 [PubMed]
• Lai Carmen, Horlings Hugo M., van de Vijver Marc J., van Beers Eric H., Nederlof Petra M., Wessels Lodewyk F. A., Reinders Marcel J. T. SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets BMC bioinformatics 2007;8:422 [PubMed]
• Dowsett Mitch, Hanna Wedad M., Kockx Mark, Penault-Llorca Frederique, Rüschoff Josef, Gutjahr Thorsten, Habben Kai, van de Vijver Marc J. Standardization of HER2 testing: results of an international proficiency-testing ring study Modern pathology 2007;20 (5):584-591 [PubMed]
• Welm Alana L., Sneddon Julie B., Taylor Carmen, Nuyten Dimitry S. A., van de Vijver Marc J., Hasegawa Bruce H., Bishop J. Michael The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans Proceedings of the National Academy of Sciences of the United States of America 2007;104 (18):7570-7575 [PubMed]
• Bueno-de-Mesquita Jolien M., van Harten Wim H., Retel Valesca P., van't Veer Laura J., van Dam Frits S. A. M., Karsenberg Kim, Douma Kirsten F. L., van Tinteren Harm, Peterse Johannes L., Wesseling Jelle, Wu Tin S., Atsma Douwe, Rutgers Emiel J. T., Brink Guido, Floore Arno N., Glas Annuska M., Roumen Rudi M. H., Bellot Frank E., van Krimpen Cees, Rodenhuis Sjoerd, van de Vijver Marc J., Linn Sabine C. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) lancet oncology 2007;8 (12):1079-1087 [PubMed]

2006

• Green J. A., Berns E. M. J. J., Coens C., van Luijk I., Thompson-Hehir J., van Diest P., Verheijen R. H. M., van de Vijver M., van Dam P., Kenter G. G., Tjalma W., Ewing P. C., Teodorovic I., Vergote I., van der Burg M. E. L. Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865) European journal of cancer (Oxford, England 2006;42 (15):2539-2548 [PubMed]
• Hannemann Juliane, Velds Arno, Halfwerk Johannes B. G., Kreike Bas, Peterse Johannes L., van de Vijver Marc J. Classification of ductal carcinoma in situ by gene expression profiling Breast cancer research 2006;8 (5):R61 [PubMed]
• Rodenhuis S., Bontenbal M., van Hoesel Q. G. C. M., Smit W. M., Nooij M. A., Voest E. E., van der Wall E., Hupperets P., van Tinteren H., Peterse J. L., van de Vijver M. J., de Vries E. G. E. Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer Annals of oncology 2006;17 (4):588-596 [PubMed]
• Kreike Bas, Halfwerk Hans, Kristel Petra, Glas Annuska, Peterse Hans, Bartelink Harry, van de Vijver Marc J. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy Clinical cancer research 2006;12 (19):5705-5712 [PubMed]
• Sotiriou Christos, Wirapati Pratyaksha, Loi Sherene, Harris Adrian, Fox Steve, Smeds Johanna, Nordgren Hans, Farmer Pierre, Praz Viviane, Haibe-Kains Benjamin, Desmedt Christine, Larsimont Denis, Cardoso Fatima, Peterse Hans, Nuyten Dimitry, Buyse Marc, van de Vijver Marc J., Bergh Jonas, Piccart Martine, Delorenzi Mauro Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis Journal of the National Cancer Institute 2006;98 (4):262-272 [PubMed]
• Chi Jen-Tsan, Wang Zhen, Nuyten Dimitry S. A., Rodriguez Edwin H., Schaner Marci E., Salim Ali, Wang Yun, Kristensen Gunnar B., Helland Aslaug, Børresen-Dale Anne-Lise, Giaccia Amato, Longaker Michael T., Hastie Trevor, Yang George P., van de Vijver Marc J., Brown Patrick O. Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers PLoS medicine 2006;3 (3):e47 [PubMed]
• Nuyten Dimitry S. A., van de Vijver Marc J. Gene expression signatures to predict the development of metastasis in breast cancer Breast disease 2006;26:149-156 [PubMed]
• Adler Adam S., Lin Meihong, Horlings Hugo, Nuyten Dimitry S. A., van de Vijver Marc J., Chang Howard Y. Genetic regulators of large-scale transcriptional signatures in cancer Nature genetics 2006;38 (4):421-430 [PubMed]
• Hannemann J., Kristel P., van Tinteren H., Bontenbal M., van Hoesel Q. G. C. M., Smit W. M., Nooij M. A., Voest E. E., van der Wall E., Hupperets P., de Vries E. G. E., Rodenhuis S., van de Vijver M. J. Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy British journal of cancer 2006;95 (10):1334-1341 [PubMed]
• Nuyten Dimitry S. A., Kreike Bas, Hart Augustinus A. M., Chi Jen-Tsan Ashley, Sneddon Julie B., Wessels Lodewyk F. A., Peterse Hans J., Bartelink Harry, Brown Patrick O., Chang Howard Y., van de Vijver Marc J. Predicting a local recurrence after breast-conserving therapy by gene expression profiling Breast cancer research 2006;8 (5):R62 [PubMed]
• Abdullah-Sayani Ambreen, Bueno-de-Mesquita Jolien M., van de Vijver Marc J. Technology Insight: tuning into the genetic orchestra using microarrays--limitations of DNA microarrays in clinical practice Nature clinical practice. Oncology 2006;3 (9):501-516 [PubMed]
• Riegman P. H. J., Dinjens W. N. M., Oomen M. H. A., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., Lopez-Guerrero J. A., Llombart Bosch A., Carbone A., Gloghini A., Teodorovic I., Isabelle M., Jaminé D., Passioukov A., Lejeune S., Therasse P., van Veen E.-B., Lam K. H., Oosterhuis J. W. TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview European journal of cancer (Oxford, England 2006;42 (16):2678-2683 [PubMed]
• Morente M. M., Mager R., Alonso S., Pezzella F., Spatz A., Knox K., Kerr D., Dinjens W. N. M., Oosterhuis J. W., Lam K. H., Oomen M. H. A., van Damme B., van de Vijver M., van Boven H., Kerjaschki D., Pammer J., Lopez-Guerrero J. A., Llombart Bosch A., Carbone A., Gloghini A., Teodorovic I., Isabelle M., Passioukov A., Lejeune S., Therasse P., van Veen E.-B., Ratcliffe C., Riegman P. H. J. TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network European journal of cancer (Oxford, England 2006;42 (16):2684-2691 [PubMed]
• van Veen E.-B., Riegman P. H. J., Dinjens W. N. M., Lam K. H., Oomen M. H. A., Spatz A., Mager R., Ratcliffe C., Knox K., Kerr D., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., Lopez-Guerrero J. A., Llombart Bosch A., Carbone A., Gloghini A., Teodorovic I., Isabelle M., Passioukov A., Lejeune S., Therasse P., Oosterhuis J. W. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe European journal of cancer (Oxford, England 2006;42 (17):2914-2923 [PubMed]
• Lopez-Guerrero J. A., Riegman P. H. J., Oosterhuis J. W., Lam K. H., Oomen M. H. A., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., Carbone A., Gloghini A., Teodorovic I., Isabelle M., Passioukov A., Lejeune S., Therasse P., van Veen E.-B., Dinjens W. N. M., Llombart-Bosch A. TuBaFrost 4: access rules and incentives for a European tumour bank European journal of cancer (Oxford, England 2006;42 (17):2924-2929 [PubMed]
• Isabelle M., Teodorovic I., Morente M. M., Jaminé D., Passioukov A., Lejeune S., Therasse P., Dinjens W. N. M., Oosterhuis J. W., Lam K. H., Oomen M. H. A., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van de Vijver M., van Boven H., Alonso S., Kerjaschki D., Pammer J., Lopez-Guerrero J. A., Llombart Bosch A., Carbone A., Gloghini A., van Veen E.-B., van Damme B., Riegman P. H. J. TuBaFrost 5: multifunctional central database application for a European tumor bank European journal of cancer (Oxford, England 2006;42 (18):3103-3109 [PubMed]
• Teodorovic I., Isabelle M., Carbone A., Passioukov A., Lejeune S., Jaminé D., Therasse P., Gloghini A., Dinjens W. N. M., Lam K. H., Oomen M. H. A., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., Lopez-Guerrero J. A., Llombart Bosch A., van Veen E.-B., Oosterhuis J. W., Riegman P. H. J. TuBaFrost 6: virtual microscopy in virtual tumour banking European journal of cancer (Oxford, England 2006;42 (18):3110-3116 [PubMed]
• Riegman P. H. J., Oomen M. H. A., Dinjens W. N. M., Oosterhuis J. W., Lam K. H., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., López-Guerrero J. A., Llombart-Bosch A., Carbone A., Gloghini A., Teodorovic I., Isabelle M., Passioukov A., Lejeune S., Therasse P., van Veen E. B. TuBaFrost: European virtual tumor tissue banking Advances in experimental medicine and biology 2006;587:65-74 [PubMed]
• Isabelle M., Teodorovic I., Oosterhuis J. W., Riegman P. H. J., Passioukov A., Lejeune S., Therasse P., Dinjens W. N. M., Lam K. H., Oomen M. H. A., Spatz A., Ratcliffe C., Knox K., Mager R., Kerr D., Pezzella F., van Damme B., van de Vijver M., van Boven H., Morente M. M., Alonso S., Kerjaschki D., Pammer J., López-Guerrero J. A., Llombart-Bosch A., Carbone A., Gloghini A., van Veen E. B. Virtual microscopy in virtual tumor banking Advances in experimental medicine and biology 2006;587:75-86 [PubMed]

2005

• Dai Hongyue, van't Veer Laura, Lamb John, He Yudong D., Mao Mao, Fine Bernard M., Bernards Rene, van de Vijver Marc, Deutsch Paul, Sachs Alan, Stoughton Roland, Friend Stephen A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients Cancer research 2005;65 (10):4059-4066 [PubMed]
• van de Vijver Marc J. Biological variables and prognosis of DCIS Breast (Edinburgh, Scotland) 2005;14 (6):509-519 [PubMed]
• Hannemann Juliane, Oosterkamp Hendrika M., Bosch Cathy A. J., Velds Arno, Wessels Lodewyk F. A., Loo Claudette, Rutgers Emiel J., Rodenhuis Sjoerd, van de Vijver Marc J. Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer Journal of clinical oncology 2005;23 (15):3331-3342 [PubMed]
• West Robert B., Nuyten Dimitry S. A., Subramanian Subbaya, Nielsen Torsten O., Corless Christopher L., Rubin Brian P., Montgomery Kelli, Zhu Shirley, Patel Rajiv, Hernandez-Boussard Tina, Goldblum John R., Brown Patrick O., van de Vijver Marc, van de Rijn Matt Determination of stromal signatures in breast carcinoma PLoS biology 2005;3 (6):e187 [PubMed]
• van de Vijver Marc Gene-expression profiling and the future of adjuvant therapy oncologist 2005;10 (Suppl. 2):30-34 [PubMed]
• Voogd A. C., van Oost F. J., Rutgers E. J. T., Elkhuizen P. H. M., van Geel A. N., Scheijmans L. J. E. E., van der Sangen M. J. C., Botke G., Hoekstra C. J., Jobsen J. J., van de Velde C. J. H., von Meyenfeldt M. F., Tabak J. M., Peterse J. L., van de Vijver M. J., Coebergh J. W. W., van Tienhoven G. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer European journal of cancer (Oxford, England 2005;41 (17):2637-2644 [PubMed]
• Faneyte I. F. Markers for effectiveness of chemotherapy and drug resistance in breast cancer 2005. 162p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Rodenhuis S.; Co-supervisor: van de Vijver M. J.)
• Lakhani Sunil R., Reis-Filho Jorge S., Fulford Laura, Penault-Llorca Frederique, van der Vijver Marc, Parry Suzanne, Bishop Timothy, Benitez Javier, Rivas Carmen, Bignon Yves-Jean, Chang-Claude Jenny, Hamann Ute, Cornelisse Cees J., Devilee Peter, Beckmann Matthias W., Nestle-Krämling Carolin, Daly Peter A., Haites Neva, Varley Jenny, Lalloo Fiona, Evans Gareth, Maugard Christine, Meijers-Heijboer Hanne, Klijn Jan G. M., Olah Edith, Gusterson Barry A., Pilotti Silvana, Radice Paolo, Scherneck Siegfried, Sobol Hagay, Jacquemier Jocelyne, Wagner Teresa, Peto Julian, Stratton Michael R., McGuffog Lesley, Easton Douglas F. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clinical cancer research 2005;11 (14):5175-5180 [PubMed]
• Chang Howard Y., Nuyten Dimitry S. A., Sneddon Julie B., Hastie Trevor, Tibshirani Robert, Sørlie Therese, Dai Hongyue, He Yudong D., van't Veer Laura J., Bartelink Harry, van de Rijn Matt, Brown Patrick O., van de Vijver Marc J. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proceedings of the National Academy of Sciences of the United States of America 2005;102 (10):3738-3743 [PubMed]

2004

• Cleton-Jansen Anne-Marie, Timmerman Michel C., van de Vijver Marc J., van Asperen Christi J., Kroon Herman M., Eilers Paul H. C., Hogendoorn Pancras C. W. A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient Laboratory investigation; a journal of technical methods and pathology 2004;84 (2):191-202 [PubMed]
• Olivier R. I., van Beurden M., Lubsen M. A. C., Rookus M. A., Mooij T. M., van de Vijver M. J., van't Veer L. J. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up British journal of cancer 2004;90 (8):1492-1497 [PubMed]
• Cleton-Jansen Anne-Marie, Buerger Horst, ter Haar Natalja, Philippo Katja, van de Vijver Marc J., Boecker Werner, Smit Vincent T. H. B. M., Cornelisse Cees J. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer Genes, chromosomes & cancer 2004;41 (2):109-116 [PubMed]
• Perez Edith A., Pusztai Lajos, van de Vijver Marc Improving patient care through molecular diagnostics Seminars in oncology 2004;31 (5 Suppl 10):14-20 [PubMed]
• Faneyte Ian F., Kristel Petra M. P., van de Vijver Marc J. Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer Anticancer research 2004;24 (5A):2931-2939 [PubMed]
• van der Hage J. A., van den Broek L. J. C. M., Legrand C., Clahsen P. C., Bosch C. J. A., Robanus-Maandag E. C., van de Velde C. J. H., van de Vijver M. J. Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients British journal of cancer 2004;90 (8):1543-1550 [PubMed]
• Anninga J. K., van de Vijver M. J., Cleton-Jansen A. M., Kristel P. M. P., Taminiau A. H. M., Nooij M., Egeler R. M., Hogendoorn P. C. W. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas European journal of cancer (Oxford, England 2004;40 (7):963-970 [PubMed]
• Faneyte Ian F., Peterse Johannes L., van Tinteren Harm, Pronk Corina, Bontenbal Marijike, Beex Louk V. A. M., van der Wall Elsken, Richel Dick J., Nooij Marianne A., Voest Emile E., Hupperets Pierre, ten Vergert Elisabeth M., de Vries Elisabeth G. E., Rodenhuis Sjoerd, van de Vijver Marc J. Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement Clinical cancer research 2004;10 (13):4457-4463 [PubMed]

2003

• Robanus-Maandag Els C., Bosch Cathy A. J., Kristel Petra M., Hart Augustinus A. M., Faneyte Ian F., Nederlof Petra M., Peterse Johannes L., van de Vijver Marc J. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas Journal of pathology 2003;201 (1):75-82 [PubMed]
• Faneyte I. F., Schrama J. G., Peterse J. L., Remijnse P. L., Rodenhuis S., van de Vijver M. J. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome British journal of cancer 2003;88 (3):406-412 [PubMed]
• Bilous Michael, Dowsett Mitch, Hanna Wedad, Isola Jorma, Lebeau Annette, Moreno Aberlardo, Penault-Llorca Frédérique, Rüschoff Josef, Tomasic Gorana, van de Vijver Marc Current perspectives on HER2 testing: a review of national testing guidelines Modern pathology 2003;16 (2):173-182 [PubMed]
• van 't Veer Laura J., Dai Hongyue, van de Vijver Marc J., He Yudong D., Hart Augustinus A. M., Bernards René, Friend Stephen H. Expression profiling predicts outcome in breast cancer Breast cancer research 2003;5 (1):57-58 [PubMed]
• Bonnefoi H., Diebold-Berger S., Therasse P., Hamilton A., van de Vijver M., Macgrogan G., Shepherd L., Amaral N., Duval C., Drijkoningen R., Larsimont D., Piccart M. Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome? Annals of oncology 2003;14 (3):406-413 [PubMed]
• van Ruth S., Acherman Y. I. Z., van de Vijver M. J., Hart A. A. M., Verwaal V. J., Zoetmulder F. A. N. Pseudomyxoma peritonei: a review of 62 cases European journal of surgical oncology 2003;29 (8):682-688 [PubMed]
• Baas P., Ardizzoni A., Grossi F., Nackaerts K., Numico G., van Marck E., van de Vijver M., Monetti F., Smid-Geirnaerdt M. J. A., van Zandwijk N., Debruyne C., Legrand C., Giaccone G. The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992) European journal of cancer (Oxford, England 2003;39 (3):353-357 [PubMed]
• van de Vijver Marc J., Peterse Hans The diagnosis and management of pre-invasive breast disease: pathological diagnosis--problems with existing classifications Breast cancer research 2003;5 (5):269 [PubMed]
• Schouwink J. Hugo, Kool Leo Schultze, Rutgers Emiel J., Zoetmulder Frans A. N., van Zandwijk Nico, v d Vijver Marc J., Baas Paul The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma Annals of thoracic surgery 2003;75 (6):1715-8; discussion 1718-9 [PubMed]

2002

• van de Vijver Marc J., He Yudong D., van't Veer Laura J., Dai Hongyue, Hart Augustinus A. M., Voskuil Dorien W., Schreiber George J., Peterse Johannes L., Roberts Chris, Marton Matthew J., Parrish Mark, Atsma Douwe, Witteveen Anke T., Glas Annuska, Delahaye Leonie, van der Velde Tony, Bartelink Harry, Rodenhuis Sjoerd, Rutgers Emiel T., Friend Stephen H., Bernards René A gene-expression signature as a predictor of survival in breast cancer New England journal of medicine 2002;347 (25):1999-2009 [PubMed]
• Spermon J. R., Roeleveld T. A., van der Poel H. G., Hulsbergen-van de Kaa C. A., ten Bokkel Huinink W. W., van de Vijver M., Witjes J. A., Horenblas S. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors Urology 2002;59 (6):923-929 [PubMed]
• van de Vijver Marc Emerging technologies for HER2 testing Oncology 2002;63 (Suppl. 1):33-38 [PubMed]
• Faneyte Ian F., Kristel Petra M. P., Maliepaard Marc, Scheffer George L., Scheper Rik J., Schellens Jan H. M., van de Vijver Marc J. Expression of the breast cancer resistance protein in breast cancer Clinical cancer research 2002;8 (4):1068-1074 [PubMed]
• van 't Veer Laura J., Dai Hongyue, van de Vijver Marc J., He Yudong D., Hart Augustinus A. M., Mao Mao, Peterse Hans L., van der Kooy Karin, Marton Matthew J., Witteveen Anke T., Schreiber George J., Kerkhoven Ron M., Roberts Chris, Linsley Peter S., Bernards René, Friend Stephen H. Gene expression profiling predicts clinical outcome of breast cancer Nature 2002;415 (6871):530-536 [PubMed]
• Schrama J. G., Faneyte I. F., Schornagel J. H., Baars J. W., Peterse J. L., van de Vijver M. J., Dalesio O., van Tinteren H., Rutgers E. J. T., Richel D. J., Rodenhuis S. Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up Annals of oncology 2002;13 (5):689-698 [PubMed]
• Lakhani Sunil R., van de Vijver Marc J., Jacquemier Jocelyne, Anderson Thomas J., Osin Peter P., McGuffog Lesley, Easton Douglas F. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 Journal of clinical oncology 2002;20 (9):2310-2318 [PubMed]

2001

• van de Vijver M. J. Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2) European journal of cancer (Oxford, England 2001;37 (Suppl. 1):S11-S17 [PubMed]
• de Bock G. H., Tollenaar R. A., Papelard H., Cornelisse C. J., Devilee P., van de Vijver M. J. Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients British journal of cancer 2001;85 (9):1347-1350 [PubMed]
• Faneyte I. F., Kristel P. M., van de Vijver M. J. Determining MDR1/P-glycoprotein expression in breast cancer International journal of cancer. Journal international du cancer 2001;93 (1):114-122 [PubMed]
• Bijker N., Peterse J. L., Duchateau L., Robanus-Maandag E. C., Bosch C. A., Duval C., Pilotti S., van de Vijver M. J. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ British journal of cancer 2001;84 (4):539-544 [PubMed]
• Elkhuizen P. H., Hermans J., Leer J. W., van de Vijver M. J. Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increased risk on distant metastasis International journal of radiation oncology, biology, physics 2001;50 (2):387-396 [PubMed]
• Bijker N., Peterse J. L., Duchateau L., Julien J. P., Fentiman I. S., Duval C., Di Palma S., Simony-Lafontaine J., de Mascarel I., van de Vijver M. J. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853 Journal of clinical oncology 2001;19 (8):2263-2271 [PubMed]
• Maliepaard M., Scheffer G. L., Faneyte I. F., van Gastelen M. A., Pijnenborg A. C., Schinkel A. H., van de Vijver M. J., Scheper R. J., Schellens J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer research 2001;61 (8):3458-3464 [PubMed]
• Roeleveld T. A., Horenblas S., Meinhardt W., van de Vijver M., Kooi M., ten Bokkel Huinink W. W. Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients Journal of urology 2001;166 (6):2166-2170 [PubMed]

2000

• van den Broek L. J., van de Vijver M. J. Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections Applied immunohistochemistry & molecular morphology 2000;8 (4):316-321 [PubMed]
• Hamilton A., Larsimont D., Paridaens R., Drijkoningen M., van de Vijver M., Bruning P., Hanby A., Houston S., Treilleux I., Guastalla J. P., van Vreckem A., Sylvester R., Piccart M. A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923 Clinical breast cancer 2000;1 (3):233-40; discussion 241-2 [PubMed]
• Gaarenstroom K. N., Kenter G. G., Bonfrer J. M., Korse C. M., van de Vijver M. J., Fleuren G. J., Trimbos J. B. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecologic oncology 2000;77 (1):164-170 [PubMed]
• Kersemaekers A. M., van de Vijver M. J., Fleuren G. J. Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix. A report of two cases International journal of gynecological pathology 2000;19 (3):225-230 [PubMed]
• Elkhuizen P. H., van Slooten H. J., Clahsen P. C., Hermans J., van de Velde C. J., van den Broek L. C., van de Vijver M. J. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study Journal of clinical oncology 2000;18 (5):1075-1083 [PubMed]
• Mandard A. M., Denoux Y., Herlin P., Duigou F., van de Vijver M. J., Clahsen P. C., van den Broek L., Sahmoud T. M., Henry-Amar M., van de Velde C. J. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density Cancer 2000;89 (8):1748-1757 [PubMed]
• Jacobs J. J., Keblusek P., Robanus-Maandag E., Kristel P., Lingbeek M., Nederlof P. M., van Welsem T., van de Vijver M. J., Koh E. Y., Daley G. Q., van Lohuizen M. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers Nature genetics 2000;26 (3):291-299 [PubMed]
• Kenter G. G., Hellebrekers B. W., Zwinderman K. H., van de Vijver M., Peters L. A., Trimbos J. B. The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma Acta obstetricia et gynecologica Scandinavica 2000;79 (1):72-76 [PubMed]
• Lakhani S. R., Gusterson B. A., Jacquemier J., Sloane J. P., Anderson T. J., van de Vijver M. J., Venter D., Freeman A., Antoniou A., McGuffog L., Smyth E., Steel C. M., Haites N., Scott R. J., Goldgar D., Neuhausen S., Daly P. A., Ormiston W., McManus R., Scherneck S., Ponder B. A., Futreal P. A., Peto J., Stoppa-Lyonnet D., Bignon Y. J., Stratton M. R. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2 Clinical cancer research 2000;6 (3):782-789 [PubMed]
• de Bree E., Witkamp A., van de Vijver M., Zoetmulde F. Unusual origins of Pseudomyxoma peritonei Journal of surgical oncology 2000;75 (4):270-274 [PubMed]

1999

• Snijders-Keilholz A., Hellebrekers B. W., Zwinderman A. H., van de Vijver M. J., Trimbos J. B. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996) Radiotherapy and oncology 1999;51 (2):161-167 [PubMed]
• Vos C. B., ter Haar N. T., Peterse J. L., Cornelisse C. J., van de Vijver M. J. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast Journal of pathology 1999;187 (3):279-284 [PubMed]
• Zonderland H. M., Coerkamp E. G., Hermans J., van de Vijver M. J., van Voorthuisen A. E. Diagnosis of breast cancer: contribution of US as an adjunct to mammography Radiology 1999;213 (2):413-422 [PubMed]
• Kersemaekers A. M., van de Vijver M. J., Kenter G. G., Fleuren G. J. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix Genes, chromosomes & cancer 1999;26 (4):346-354 [PubMed]
• Vos C. B., ter Haar N. T., Rosenberg C., Peterse J. L., Cleton-Jansen A. M., Cornelisse C. J., van de Vijver M. J. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type British journal of cancer 1999;81 (8):1410-1418 [PubMed]
• Voogd A. C., Peterse J. L., Crommelin M. A., Rutgers E. J., Botke G., Elkhuizen P. H., van Geel A. N., Hoekstra C. J., van Pel R., van de Vijver M. J., Coebergh J. W. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) European journal of cancer (Oxford, England 1999;35 (13):1828-1837 [PubMed]
• Krul E. J. T., van de Vijver M. J., Schuuring E., van Kanten R. W., Peters A. A. W., Fleuren G. J. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country International journal of gynecological cancer 1999;9 (3):206-211 [PubMed]
• van Slooten H. J., van de Vijver M. J., Borresen A. L., Eyfjörd J. E., Valgardsdóttir R., Scherneck S., Nesland J. M., Devilee P., Cornelisse C. J., van Dierendonck J. H. Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma Journal of pathology 1999;189 (4):504-513 [PubMed]
• Kersemaekers A. M., Fleuren G. J., Kenter G. G., van den Broek L. J., Uljee S. M., Hermans J., van de Vijver M. J. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis Clinical cancer research 1999;5 (3):577-586 [PubMed]
• Elkhuizen P. H., Voogd A. C., van den Broek L. C., Tan I. T., van Houwelingen H. C., Leer J. W., van de Vijver M. J. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression International journal of radiation oncology, biology, physics 1999;45 (1):73-83 [PubMed]
• van de Vijver M. J. The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era: historical perspectives Breast cancer research 1999;1 (1):27-30 [PubMed]
• Clahsen P. C., van de Velde C. J., Duval C., Pallud C., Mandard A. M., Delobelle-Deroide A., van den Broek L., van de Vijver M. J. The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer European journal of surgical oncology 1999;25 (4):356-363 [PubMed]
• Aalders M. C., van de Vange N., Stewart F. A., Klein M. G., van de Vijver Mark J., Sterenborg H. J. White-light toxicity, resulting from systemically administered 5-aminolevulinic acid, under normal operating conditions Journal of photochemistry and photobiology. B, Biology 1999;50 (2-3):88-93 [PubMed]

1998

• Kersemaekers A. M., Kenter G. G., Hermans J., Fleuren G. J., van de Vijver M. J. Allelic loss and prognosis in carcinoma of the uterine cervix International journal of cancer. Journal international du cancer 1998;79 (4):411-417 [PubMed]
• van de Vijver M. J. Ductal carcinoma in situ of the breast: histological classification and genetic alterations Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 1998;152:123-134 [PubMed]
• Elkhuizen P. H., van de Vijver M. J., Hermans J., Zonderland H. M., van de Velde C. J., Leer J. W. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival International journal of radiation oncology, biology, physics 1998;40 (4):859-867 [PubMed]
• van Slooten H. J., van de Vijver M. J., van de Velde C. J., van Dierendonck J. H. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity British journal of cancer 1998;77 (5):789-796 [PubMed]
• Kersemaekers A. M., Hermans J., Fleuren G. J., van de Vijver M. J. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix British journal of cancer 1998;77 (2):192-200 [PubMed]
• Lakhani S. R., Jacquemier J., Sloane J. P., Gusterson B. A., Anderson T. J., van de Vijver M. J., Farid L. M., Venter D., Antoniou A., Storfer-Isser A., Smyth E., Steel C. M., Haites N., Scott R. J., Goldgar D., Neuhausen S., Daly P. A., Ormiston W., McManus R., Scherneck S., Ponder B. A., Ford D., Peto J., Stoppa-Lyonnet D., Bignon Y. J., Struewing J. P., Spurr N. K., Bishop D. T., Klijn J. G., Devilee P., Cornelisse C. J., Lasset C., Lenoir G., Barkardottir R. B., Egilsson V., Hamann U., Chang-Claude J., Sobol H., Weber B., Stratton M. R., Easton D. F. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations Journal of the National Cancer Institute 1998;90 (15):1138-1145 [PubMed]
• Clahsen P. C., van de Velde C. J., Duval C., Pallud C., Mandard A. M., Delobelle-Deroide A., van den Broek L., Sahmoud T. M., van de Vijver M. J. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer Journal of clinical oncology 1998;16 (2):470-479 [PubMed]

1997

• Vos C. B., Cleton-Jansen A. M., Berx G., de Leeuw W. J., ter Haar N. T., van Roy F., Cornelisse C. J., Peterse J. L., van de Vijver M. J. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis British journal of cancer 1997;76 (9):1131-1133 [PubMed]
• Veenhuizen R. B., Ruevekamp M. C., Oppelaar H., Ransdorp B., van de Vijver M., Helmerhorst T. J., Kenemans P., Stewart F. A. Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxicity Photochemistry and photobiology 1997;66 (3):389-395 [PubMed]
• de Leeuw W. J., Berx G., Vos C. B., Peterse J. L., van de Vijver M. J., Litvinov S., van Roy F., Cornelisse C. J., Cleton-Jansen A. M. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ Journal of pathology 1997;183 (4):404-411 [PubMed]
• Cornelis R. S., van Vliet M., van de Vijver M. J., Vasen H. F., Voute P. A., Top B., Khan P. M., Devilee P., Cornelisse C. J. Three germline mutations in the TP53 gene Human mutation 1997;9 (2):157-163 [PubMed]

1996

• van Slooten H. J., Clahsen P. C., van Dierendonck J. H., Duval C., Pallud C., Mandard A. M., Delobelle-Deroide A., van de Velde C. J., van de Vijver M. J. Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy British journal of cancer 1996;74 (1):78-85 [PubMed]
• Zonderland H. M., van de Velde C. J., van de Vijver M. J., Hermans J. Preoperatieve naaldbiopsie: een aanwinst bij palpabele mammatumoren met sterke aanwijzingen voor maligniteit Nederlands tijdschrift voor geneeskunde 1996;140 (39):1952-1956 [PubMed]

1995

• Berx G., Cleton-Jansen A. M., Nollet Friedel, de Leeuw W. J., van de Vijver M., Cornelisse C., van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers EMBO journal 1995;14 (24):6107-6115 [PubMed]

1994

• Holland R., Peterse J. L., Millis R. R., Eusebi V., Faverly D., van de Vijver M. J., Zafrani B. Ductal carcinoma in situ: a proposal for a new classification Seminars in diagnostic pathology 1994;11 (3):167-180 [PubMed]
• Cornelis R. S., van Vliet M., Vos C. B., Cleton-Jansen A. M., van de Vijver M. J., Peterse J. L., Khan P. M., Børresen A. L., Cornelisse C. J., Devilee P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations Cancer research 1994;54 (15):4200-4206 [PubMed]
• Devilee P., Schuuring E., van de Vijver M. J., Cornelisse C. J. Recent developments in the molecular genetic understanding of breast cancer Critical reviews in oncogenesis 1994;5 (2-3):247-270 [PubMed]

1993

• van de Vijver M. J. Molecular genetic changes in human breast cancer Advances in cancer research 1993;61:25-56 [PubMed]

1992

• Schuuring E., Verhoeven E., van Tinteren H., Peterse J. L., Nunnink B., Thunnissen F. B., Devilee P., Cornelisse C. J., van de Vijver M. J., Mooi W. J. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer Cancer research 1992;52 (19):5229-5234 [PubMed]

1991

• Beerman H., Bonsing B. A., van de Vijver M. J., Hermans J., Kluin P. M., Caspers R. J., van de Velde C. J., Cornelisse C. J. DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy British journal of cancer 1991;64 (1):139-143 [PubMed]
• van de Vijver M. J., Kumar R., Mendelsohn J. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly Journal of biological chemistry 1991;266 (12):7503-7508 [PubMed]
• van de Vijver M. J., Nusse R. The molecular biology of breast cancer BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1991;1072 (1):33-50 [PubMed]

1990

• Schuuring E., van der Leede B. J., Willems R., Daams H., van der Valk Martin, van de Vijver M., van Leeuwen F., Sonnenberg A., Nusse R. Differentiation-dependent expression of provirus-activated int-1 oncogene in clonal cell lines derived from a mouse mammary tumor Oncogene 1990;5 (4):459-465 [PubMed]
• van Leeuwen F., van de Vijver M. J., Lomans J., van Deemter L., Jenster G., Akiyama T., Yamamoto T., Nusse R. Mutation of the human neu protein facilitates down-modulation by monoclonal antibodies Oncogene 1990;5 (4):497-503 [PubMed]

1989

• de Potter C. R., van Daele S., van de Vijver M. J., Pauwels C., Maertens G., de Boever J., Vandekerckhove D., Roels H. The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues Histopathology 1989;15 (4):351-362 [PubMed]

1988

• van de Vijver M. J., Mooi W. J., Peterse J. L., Nusse R. Amplification and over-expression of the neu oncogene in human breast carcinomas European journal of surgical oncology 1988;14 (2):111-114 [PubMed]
• van de Vijver M. J., Mooi W. J., Wisman P., Peterse J. L., Nusse R. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA Oncogene 1988;2 (2):175-178 [PubMed]
• van de Vijver M. J., Peterse J. L., Mooi W. J., Wisman P., Lomans J., Dalesio O., Nusse R. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer New England journal of medicine 1988;319 (19):1239-1245 [PubMed]

1987

• van de Vijver M., van de Bersselaar R., Devilee P., Cornelisse C., Peterse J., Nusse R. Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene Molecular and cellular biology 1987;7 (5):2019-2023 [PubMed]

1983

• Bartelink H., van Dongen J. A., van Dam F. S., van de Vijver M. Borstsparende behandeling bij het operabele mammacarcinoom; eerste beoordeling van de resultaten Nederlands tijdschrift voor geneeskunde 1983;127 (49):2223-2228 [PubMed]

1977

• Fevery J., van de Vijver M., Michiels R., Heirwegh K. P. Comparison in different species of biliary bilirubin-IX alpha conjugates with the activities of hepatic and renal bilirubin-IX alpha-uridine diphosphate glycosyltransferases Biochemical journal 1977;164 (3):737-746 [PubMed]

1972

• Heirwegh K. P., van de Vijver M., Fevery J. Assay and properties of dititonin-activated bilirubin uridine diphosphate glucuronyltransferase from rat liver Biochemical journal 1972;129 (3):605-618 [PubMed]
• Mertens B. B., van de Vijver M., Heirwegh K. P. Determination of bilirubin in liver homogenate with diazotized p-iodoaniline. Improvement of color recovery by incorporation of antioxidant (2,6-di-tert-butyl-p-cresol) in the reaction system Analytical biochemistry 1972;50 (2):652-655 [PubMed]
• Fevery J., Leroy P., van de Vijver M., Heirwegh K. P. Structures of bilirubin conjugates synthesized in vitro from bilirubin and uridine diphosphate glucuronic acid, uridine diphosphate glucose or uridine diphosphate xylose by preparations from rat liver Biochemical journal 1972;129 (3):635-644 [PubMed]